Extreme obesity with alveolar hypoventilation

E4_OBESITYXTRMALV

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66.2 Hospital discharge: ICD-9 — 2788A Cause of death: ICD-10 — E66.2 Cause of death: ICD-9 — 2788A 2 out of 7 registries used, show all original rules.	1782
4. Check minimum number of events None	1782
5. Include endpoints None	1782
6. Filter based on genotype QC (FinnGen only)	1589

Control definitions (FinnGen only)

Control exclude: E4_OBESITY

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E66
Name in latin: Obesitas extrema cum hypoventilatione alveolari

NAME	E4_OBESITYXTRMALV
CONTROL_EXCLUDE	E4_OBESITY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E662
HD_ICD_9	2788A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E662
COD_ICD_9	2788A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Extreme obesity with alveolar hypoventilation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	9083	4806	4240
Only index persons	8456	4518	3938
Unadjusted period prevalence (%)
Whole population	0.13	0.14	0.12
Only index persons	0.16	0.17	0.15
Median age at first event (years)
Whole population	62.01	62.99	60.88
Only index persons	62.08	62.87	61.17

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1589	895	694
Unadjusted period prevalence (%)	0.32	0.32	0.32
Median age at first event (years)	59.85	58.86	61.13

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1637: Matched controls
16370

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A46

ICD-10 Finland

Erysipelas

7.1

315.4

645

1365

T82

ICPC

Obesity

26.8

307.7

417

206

C03CA01

ATC

furosemide; systemic

11.3

307.7

1163

2927

J96.1

ICD-10 Finland

Chronic respiratory failure

71.5

307.7

527

108

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

14.1

307.7

441

416

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

20.2

307.7

400

258

E66.00

ICD-10 Finland

Metabolic syndrome

55.0

307.7

562

154

E66

ICD-10 Finland

Obesity

17.9

307.7

406

296

WX725

NOMESCO Finland

Noninvasive ventilation

10.8

307.7

418

502

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4503599627370496.0

307.7

1636

E66.9

ICD-10 Finland

Obesity, unspecified

125.4

307.7

441

E66.8

ICD-10 Finland

Other obesity

189.0

307.7

678

XG466

NOMESCO Finland

Sleep oxymetry

23.1

307.7

327

175

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

7.7

307.7

937

2423

I50.9

ICD-10 Finland

Heart failure, unspecified

10.6

307.7

708

1101

E66.01

ICD-10 Finland

Obesity due to excess calories

72.8

307.7

889

263

G47.3

ICD-10 Finland

Sleep apnoea

17.4

307.7

1236

2468

R5140

NOMESCO Finland

Monitoring the use of the aid

11.8

307.7

716

1013

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

14.0

307.7

411

382

A10BA02

ATC

metformin; oral

7.5

307.7

1026

2987

103

Kela drug reimbursment

Diabetes, insulin-treated

6.6

307.7

942

2785

I50.0

ICD-10 Finland

Congestive heart failure

10.3

305.8

391

486

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

39.4

305.2

189

A10BJ02

ATC

liraglutide; parenteral

20.6

294.6

233

131

A10BJ06

ATC

semaglutide; parenteral

11.1

287.2

337

372

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

7.4

281.0

508

938

215

Kela drug reimbursment

Diabetes, non-insulin-treated

5.8

277.3

857

2606

T90

ICPC

Diabetes non-insulin dependent

5.7

273.8

854

2612

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

7.5

261.1

455

804

160

Kela drug reimbursment

exenatide

23.7

250.1

184

R06.0

ICD-10 Finland

Dyspnoea

5.1

235.2

881

3053

J96.0

ICD-10 Finland

Acute respiratory failure

28.2

234.9

161

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

5.8

227.6

542

1283

C03DA01

ATC

spironolactone; oral

6.1

225.3

496

1092

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

41.3

218.5

133

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

+∞

216.6

203

SPAT1262

SPAT

Handing over of treatment supplies

5.2

215.2

606

1649

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

9.5

214.2

278

346

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.7

210.1

789

2692

R03BB04

ATC

tiotropium bromide; inhalant

6.0

199.5

426

904

WX722

NOMESCO Finland

PEEP

9.5

195.5

251

307

A10AE04

ATC

insulin glargine; parenteral

6.1

190.8

394

808

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

8.6

187.2

261

353

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.7

186.2

587

1725

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.9

185.5

548

1529

SPAT1148

SPAT

Treatment of chronic ulcer or burn

5.3

184.3

471

1166

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

5.3

183.8

467

1150

S97

ICPC

Chronic ulcer skin

7.1

181.4

309

522

A10BX07

ATC

[U] liraglutide

25.9

180.4

127

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

10.4

177.3

208

225

J96.9

ICD-10 Finland

Respiratory failure, unspecified

47.2

173.5

102

J45.9

ICD-10 Finland

Asthma, unspecified

4.4

168.4

601

1922

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.3

163.4

574

1809

M04AA01

ATC

allopurinol; systemic

4.9

162.0

441

1140

A08AB01

ATC

orlistat; oral

59.5

160.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.6

154.8

461

1276

162

Kela drug reimbursment

liraglutide

24.8

152.7

109

R03AC02

ATC

salbutamol; inhalant

4.3

149.7

1249

6964

R60.0

ICD-10 Finland

Localized oedema

4.6

148.3

440

1211

A10AB05

ATC

insulin aspart; parenteral

5.9

146.7

297

590

205

Kela drug reimbursment

Chronic hypertension

3.8

146.5

692

2651

OAB72

NOMESCO Finland

Weight control and weight loss guidance

49.8

146.4

I50

ICD-10 Finland

Heart failure

10.8

141.5

159

161

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

5.6

139.4

300

629

R03AK06

ATC

salmeterol and fluticasone; inhalant

4.3

138.7

453

1335

I10

ICD-10 Finland

Essential (primary) hypertension

4.6

135.2

1348

8220

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.5

133.8

207

312

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

133.4

1122

6090

A10BH01

ATC

sitagliptin; oral

4.9

127.7

329

802

R02

ICPC

Shortness of breath/dyspnoea

4.1

126.9

439

1341

E66.0

ICD-10 Finland

Obesity due to excess calories

1316.2

126.8

122

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.5

126.5

668

2703

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.3

124.8

387

1090

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

10.2

120.8

141

150

H02AB06

ATC

prednisolone; systemic

3.4

119.5

1072

5896

A10BK03

ATC

empagliflozin; oral

4.3

116.9

361

1010

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.6

116.3

532

1950

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.4

115.8

348

953

B03BA03

ATC

hydroxocobalamin; parenteral

6.3

114.9

210

375

QBJ30

NOMESCO Finland

Correction of abdominal apron

65.5

114.2

J01FF01

ATC

clindamycin; systemic

3.3

114.2

690

2994

SPAT1254

SPAT

Administration of medicine

4.0

114.0

400

1226

L28

ICPC

Limited function/disability (L)

3.5

112.7

521

1918

A10BB12

ATC

glimepiride; oral

5.6

112.3

232

465

N05AA02

ATC

levomepromazine; systemic

7.0

111.4

180

283

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

5.1

107.7

251

559

SPAT1229

SPAT

Assessment of need for aid

5.0

107.7

257

584

A10BX04

ATC

[U] exenatide

21.3

107.0

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

7.1

105.9

169

262

A10BJ05

ATC

dulaglutide; parenteral

11.5

105.3

112

104

N05AF03

ATC

chlorprothixene; systemic

9.6

105.0

128

144

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.4

100.2

178

308

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.6

99.4

411

1396

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

9.6

98.9

120

134

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

6.9

97.1

159

253

C07AB07

ATC

bisoprolol; oral

3.0

95.6

1044

6109

N05AX12

ATC

aripiprazole; systemic

7.1

95.6

151

231

J01MA12

ATC

levofloxacin; systemic

3.3

95.5

490

1898

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.4

93.0

431

1567

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

8.1

92.2

129

172

A10AC01

ATC

insulin (human); parenteral

4.7

90.3

229

544

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

7.3

90.0

137

201

R06.2

ICD-10 Finland

Wheezing

5.9

89.5

173

324

J01CE08

ATC

benzathine benzylpenicillin; parenteral

16.1

89.3

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.1

88.1

199

429

GX2C5

NOMESCO Finland

Short-lasting oximetry

21.4

87.7

J46

ICD-10 Finland

Status asthmaticus

7.9

87.4

124

168

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.1

87.1

492

2002

M10.9

ICD-10 Finland

Gout, unspecified

4.5

87.1

235

586

B01AA03

ATC

warfarin; systemic

3.2

86.6

437

1665

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.6

85.7

344

1137

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.4

85.2

149

253

A28

ICPC

Limited function/disability NOS

3.1

84.9

458

1812

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

6.9

83.6

135

211

WX723

NOMESCO Finland

CPAP therapy

5.3

82.0

179

374

A10AE05

ATC

insulin detemir; parenteral

5.3

81.5

177

368

N05AH04

ATC

quetiapine; oral

3.1

80.1

434

1715

A08

ICPC

Swelling

4.7

79.8

204

486

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.2

78.7

401

1528

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.5

78.2

323

1083

N02AX02

ATC

tramadol; systemic, rectal

2.6

78.2

910

5301

SPAT1263

SPAT

Sampling

2.6

76.2

842

4767

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

75.8

668

3392

N06AX16

ATC

venlafaxine; oral

3.2

75.4

376

1412

K77

ICPC

Heart failure

9.1

74.2

108

R60.9

ICD-10 Finland

Oedema, unspecified

4.6

74.1

189

449

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

4.1

73.1

223

607

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

3.2

72.6

338

1216

S76

ICPC

Skin infection other

4.7

72.2

182

428

A41.9

ICD-10 Finland

Sepsis, unspecified

5.9

71.3

133

240

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.4

71.0

300

1016

A10BK01

ATC

dapagliflozin; oral

3.9

70.5

236

686

WX780

NOMESCO Finland

Remote monitoring CPAP

4.9

70.0

165

367

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.9

69.5

163

361

OAB50, ,

SPAT

3.7

69.4

250

763

J45.1

ICD-10 Finland

Nonallergic asthma

4.1

69.4

211

572

358

Kela drug reimbursment

liraglutide

21.9

68.5

GX2D5

NOMESCO Finland

Sleep oximetry

18.3

68.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

68.1

554

2679

A10BH05

ATC

linagliptin; oral

4.7

67.5

165

378

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.7

67.3

465

2072

RK320, ,

NOMESCO Finland

18.9

66.7

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.4

66.6

179

442

N03AX16

ATC

[U] pregabalin

2.6

66.5

530

2532

N06AX12

ATC

bupropion; oral

4.2

66.4

190

492

J01DB01

ATC

cefalexin; oral

4.2

65.9

1498

11746

N02AA05

ATC

oxycodone; systemic

2.8

65.6

435

1895

SPAT1301

SPAT

No procedures

2.5

65.4

641

3372

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.0

65.0

355

1393

A10BJ01

ATC

exenatide; parenteral

13.7

65.0

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.7

64.8

229

689

A10BH02

ATC

vildagliptin; oral

8.8

64.4

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

64.3

724

4045

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

3.2

64.3

304

1098

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

63.3

305

1113

N05AX08

ATC

risperidone; systemic

3.7

63.2

224

675

C09AA02

ATC

enalapril; systemic

2.7

62.9

433

1917

SPAT1255

SPAT

Intravenous administration of medicine

3.9

62.8

203

574

WX730

NOMESCO Finland

Conventional respirator

9.2

62.7

A06AD11

ATC

lactulose; oral

3.0

62.5

337

1311

B01AB05

ATC

enoxaparin; parenteral

2.4

61.8

663

3612

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

7.5

61.0

124

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

60.8

OAB72, ,

SPAT

10.0

60.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.0

59.9

182

492

N03AX09

ATC

lamotrigine; oral

4.8

59.3

142

319

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.5

59.0

229

731

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.4

58.4

155

378

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.4

57.9

584

3078

N05AH03

ATC

olanzapine; systemic

3.9

57.8

186

523

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

4.6

57.2

144

337

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

+∞

56.6

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

10.1

56.6

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

6.9

56.4

135

N05AB03

ATC

perphenazine; systemic, rectal

5.2

56.3

121

248

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

9.9

56.0

C03AA03

ATC

hydrochlorothiazide; oral

3.4

55.1

224

735

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

15.4

54.7

N06AB04

ATC

citalopram; systemic

2.5

54.6

441

2092

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.2

54.4

157

408

A12BA01

ATC

potassium chloride; oral

5.2

53.6

115

235

WX892

NOMESCO Finland

Monitored bed care

3.4

53.5

210

673

SPAT1211

SPAT

Application of soft bandage

3.4

53.4

217

711

SPAT1139

SPAT

Nutrition survey

5.2

53.4

115

236

B81

ICPC

Anaemia vit B12/folate deficiency

5.0

53.0

118

249

SPAT1260

SPAT

Consultation of another employee

2.6

53.0

385

1734

R03AK08

ATC

formoterol and beclometasone; inhalant

4.2

53.0

148

375

J45.8

ICD-10 Finland

Mixed asthma

5.5

52.8

106

204

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.0

52.7

275

1044

XG410

NOMESCO Finland

Flow-volume spirometry

4.8

52.5

125

279

J45

ICD-10 Finland

Asthma

3.1

52.4

256

936

C08CA01

ATC

amlodipine; oral

2.2

52.3

771

4712

H3600, E113,

ICD-10 Finland

13.2

52.2

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

7.4

52.0

109

SPAT1249

SPAT

Treatment-related counselling outside office

2.2

51.9

739

4449

SPAT1310

SPAT

Counselling related to known health issue

2.3

51.8

611

3409

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.3

51.6

220

742

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.2

51.6

224

764

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.0

51.3

116

248

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

6.6

51.1

133

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.6

50.8

126

291

N06AX21

ATC

duloxetine; oral

2.8

50.6

292

1168

K07

ICPC

Swollen ankles/oedema

4.1

50.6

146

379

R03BA05

ATC

fluticasone; inhalant

2.5

50.5

387

1784

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

50.3

579

3191

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.2

49.8

785

4897

R03DA04

ATC

theophylline; systemic, rectal

4.3

49.8

137

343

C09AA05

ATC

ramipril; oral

2.3

49.6

519

2745

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

49.5

859

5556

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

49.2

A10BG03

ATC

pioglitazone; oral

6.1

49.1

152

E0000UV, ,

ATC

2.1

49.0

790

4961

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

4.3

48.5

130

319

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.5

48.4

122

285

R95

ICPC

Chron obstructive pulmonary disease

5.0

47.7

107

227

SPAT1234

SPAT

Support of social functional capacity

4.1

47.7

139

363

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.5

47.6

181

567

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.8

47.6

279

1123

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.3

47.6

131

328

N06AB03

ATC

fluoxetine; oral

2.8

47.3

283

1152

SPAT1240

SPAT

Therapeutic discussion

3.1

47.2

221

786

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

5.9

46.9

152

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.5

46.8

356

1629

C01AA05

ATC

digoxin; systemic

3.6

46.5

169

514

L30.4

ICD-10 Finland

Erythema intertrigo

7.7

46.4

N06AA09

ATC

amitriptyline; systemic

3.0

46.4

237

885

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.2

46.4

131

334

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.0

46.3

236

881

207

Kela drug reimbursment

Chronic arrhythmias

2.5

46.0

338

1521

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.6

46.0

334

1495

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.3

45.7

193

645

3051, ,

Kela drug reimbursment

12.1

45.6

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.6

45.5

327

1455

R03AK07

ATC

formoterol and budesonide; inhalant

2.3

45.5

448

2297

B01AF02

ATC

apixaban; oral

2.6

45.4

304

1308

WX781

NOMESCO Finland

Remote monitoring, noninvasive ventilation

161.2

45.0

R03AK03

ATC

[U] fenoterol and ipratropium bromide

4.2

45.0

125

315

SPAT1281

SPAT

Other administrative function

3.2

44.4

189

635

L17

ICPC

Foot/toe symptom/complaint

2.1

44.4

618

3635

A10AD05

ATC

insulin aspart; parenteral

7.7

44.3

A08AA02

ATC

fenfluramine; oral

10.5

44.1

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

4.6

44.0

109

251

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.8

43.7

148

201

Kela drug reimbursment

Chronic cardiac insufficiency

3.9

43.6

138

382

N03AG01

ATC

valproic acid; systemic, rectal

3.5

43.5

157

475

N05BA04

ATC

oxazepam; oral

2.2

43.5

514

2833

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.2

43.4

465

2462

RD210, ,

NOMESCO Finland

9.0

43.3

N05CD07

ATC

temazepam; oral

2.8

43.0

253

1017

N05AH02

ATC

clozapine; systemic

6.5

43.0

113

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.9

42.9

140

EBA15

NOMESCO Finland

Extraction of multiple teeth

4.2

42.9

121

308

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.5

42.9

306

1354

C10AA01

ATC

simvastatin; oral

2.0

42.9

760

4870

SPAT1312

SPAT

General health counselling

2.1

42.9

573

3308

C09BA02

ATC

enalapril and diuretics; systemic

3.2

42.7

187

638

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.7

42.6

148

K08.3

ICD-10 Finland

Retained dental root

3.0

42.5

205

740

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.7

42.5

145

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.6

42.4

108

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

42.0

292

1276

R50.9

ICD-10 Finland

Fever, unspecified

2.5

41.9

324

1488

TKC20

NOMESCO Finland

Catheterisation of bladder

3.4

41.9

165

528

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

9.2

41.7

A02BC02

ATC

pantoprazole; systemic

2.2

41.6

1241

9569

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

3.7

41.2

138

397

SPAT1104

SPAT

Monitoring of emergency patient

3.3

40.9

162

520

ZXD05

NOMESCO Finland

Urgent procedure

2.1

40.6

557

3234

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.8

40.6

137

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

5.8

40.6

137

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.1

40.5

187

658

R03DC03

ATC

montelukast; oral

2.4

40.2

344

1651

E000001, ,

ATC

2.3

39.9

376

1879

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.8

39.9

132

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.5

39.9

150

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.1

39.9

114

293

R03BA01

ATC

beclometasone; inhalant

2.5

39.7

295

1327

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

39.7

291

1301

J01DA01

ATC

[U] cefalexin

2.0

39.6

1085

8025

P29

ICPC

Psychological sympt/compl other

3.3

39.4

162

532

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

5.1

39.2

171

N05AD01

ATC

haloperidol; systemic

5.0

39.1

183

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.0

39.1

183

N05BA01

ATC

diazepam; systemic, rectal

2.5

39.0

284

1265

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

38.9

236

962

Z02.7

ICD-10 Finland

Issue of medical certificate

3.1

38.8

173

596

P76

ICPC

Depressive disorder

3.3

38.6

153

491

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

38.2

157

515

M10

ICD-10 Finland

Gout

3.8

38.1

122

340

I50.1

ICD-10 Finland

Left ventricular failure

3.7

37.9

124

351

SPAT1243

SPAT

Psychiatric/psychological examination

5.8

37.7

125

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

37.6

341

1673

N04AA02

ATC

biperiden; systemic

6.1

37.5

112

F61.0

ICD-10 Finland

Mixed personality disorders

7.1

37.5

S18

ICPC

Laceration/cut

1.9

37.4

885

6172

N18.8

ICD-10 Finland

Other chronic renal failure

5.7

37.3

130

F34.1

ICD-10 Finland

Dysthymia

4.2

37.2

104

263

N06AB06

ATC

sertraline; oral

2.6

36.9

242

1024

N05BA06

ATC

lorazepam; systemic, sublingual

3.5

36.4

134

410

SPAT1094

SPAT

Continuous Positive Airway Pressure

8.1

36.3

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.0

36.2

175

631

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.4

35.7

214

EBA00

NOMESCO Finland

Extraction of tooth

1.9

35.6

666

4271

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

35.5

439

2433

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

35.2

586

3611

N06AX03

ATC

mianserin; oral

3.6

35.1

122

359

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

35.1

925

6627

RK110, ,

NOMESCO Finland

12.3

35.1

A10BB01

ATC

glibenclamide; oral

4.7

35.1

184

A10BG02

ATC

rosiglitazone; oral

6.9

34.9

T83

ICPC

Overweight

5.7

34.9

120

M79.6

ICD-10 Finland

Pain in limb

1.9

34.9

819

5649

J01MA14

ATC

moxifloxacin; systemic

2.7

34.8

207

833

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.9

34.7

110

SPAT1172

SPAT

Guidance concerning hydration

5.8

34.6

114

N02BE01

ATC

paracetamol; systemic, rectal

3.4

34.5

1536

13370

N05AN01

ATC

lithium; oral

5.3

34.2

137

M54.5

ICD-10 Finland

Low back pain

1.9

34.1

681

4448

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

7.3

34.0

E87.5

ICD-10 Finland

Hyperkalaemia

6.1

33.9

A10AB06

ATC

insulin glulisine; parenteral

8.6

33.6

U04

ICPC

Incontinence urine

3.1

33.5

146

495

N03AE01

ATC

clonazepam; systemic

3.2

33.5

140

463

SPAT1216

SPAT

Assessment of functional ability

2.3

33.3

303

1483

P72

ICPC

Schizophrenia

5.3

33.2

133

N05CF01

ATC

zopiclone; oral

1.9

33.2

590

3700

WX882

NOMESCO Finland

High dependency care

4.7

33.2

176

C02AC05

ATC

moxonidine; oral

3.5

33.1

119

358

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.6

33.0

213

892

S10

ICPC

Boil/carbuncle

3.1

32.6

148

514

R06.5

ICD-10 Finland

Mouth breathing

2.6

32.5

203

836

C08CA13

ATC

lercanidipine; oral

2.2

32.3

306

1521

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.0

32.1

250

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.5

32.1

189

N19

ICD-10 Finland

Unspecified kidney failure

3.9

32.1

264

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.0

32.1

152

541

TLC00

NOMESCO Finland

Insertion of intrauterine device

3.4

32.0

122

381

N03AX12

ATC

[U] gabapentin; oral

2.2

31.9

331

1706

R4190

NOMESCO Finland

Nutritional therapy

3.9

31.8

252

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.7

31.7

109

XCK10

NOMESCO Finland

Photography of fundus of eye

2.6

31.7

199

821

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.1

31.6

142

490

N17.8

ICD-10 Finland

Other acute renal failure

6.9

31.5

N06AX11

ATC

mirtazapine; oral

1.9

31.5

624

4039

L14

ICPC

Leg/thigh symptom/complaint

2.7

30.9

186

752

P99

ICPC

Psychological disorders other

4.3

30.9

195

D01AC02

ATC

miconazole; topical

2.8

30.8

169

651

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.2

30.8

127

P03

ICPC

Feeling depressed

2.7

30.7

182

730

K04.0

ICD-10 Finland

Pulpitis

2.6

30.7

197

822

J01FA06

ATC

roxithromycin; oral

1.8

30.6

706

4781

I48.2

ICD-10 Finland

Chronic atrial fibrillation

3.4

30.5

116

362

TQW80

NOMESCO Finland

Local dermatologic skincare

4.4

30.5

180

C07AB02

ATC

metoprolol; systemic

2.1

30.4

361

1956

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.6

30.3

102

294

R03BA02

ATC

budesonide; inhalant

2.1

30.2

341

1812

A10BD07

ATC

metformin and sitagliptin; systemic

3.5

30.2

109

329

M10.0

ICD-10 Finland

Idiopathic gout

3.9

30.1

248

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

30.0

202

862

AA1AD

NOMESCO Finland

CT of head and brain

1.9

29.9

544

3413

R03AC03

ATC

terbutaline; inhalant

2.3

29.9

266

1285

N06AB10

ATC

escitalopram; oral

2.1

29.8

363

1983

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

5.2

29.8

123

C01DA14

ATC

isosorbide mononitrate; oral

2.3

29.4

265

1286

R53

ICD-10 Finland

Malaise and fatigue

1.9

29.2

456

2716

H02AB07

ATC

prednisone; oral

2.3

29.1

264

1284

E86

ICD-10 Finland

Volume depletion

4.7

29.1

149

SPAT1097

SPAT

Recording of ECG

2.2

28.9

283

1421

J01AA02

ATC

doxycycline; systemic

2.1

28.8

1333

11114

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

28.7

264

1291

A10BX01

ATC

guar gum; oral

3.9

28.7

233

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.6

28.6

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.1

28.5

R96

ICPC

Asthma

2.4

28.5

209

927

IHZ05, ,

SPAT

3.9

28.3

226

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.9

28.3

231

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

5.0

28.2

129

WX872

NOMESCO Finland

Intensive care

3.1

28.2

125

428

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.1

28.1

196

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

6.1

27.9

C09CA01

ATC

losartan; oral

1.9

27.9

486

2996

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.5

27.8

193

834

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

27.7

259

1275

WX721

NOMESCO Finland

Oxygen concentrator therapy

35.7

27.5

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

9.3

27.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

27.4

716

4983

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.1

26.9

189

SPAT1167

SPAT

Insertion of urinary catheter

4.0

26.9

207

N02BF02

ATC

pregabalin; oral

2.7

26.8

158

630

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.3

26.7

226

1067

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.0

26.6

123

431

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.1

26.6

113

377

S06

ICPC

Rash localized

3.0

26.6

126

448

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

4.6

26.5

140

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.6

26.5

256

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

26.5

304

1619

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.4

26.4

306

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

26.4

137

512

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

7.5

26.4

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.8

26.3

224

N05AC02

ATC

thioridazine; oral

5.1

26.2

110

J01CF05

ATC

flucloxacillin; systemic

2.7

26.1

154

615

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.9

26.1

207

J01MA02

ATC

ciprofloxacin; systemic

1.8

26.1

665

4579

T07

ICPC

Weight gain

5.9

25.9

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.9

25.9

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

25.9

306

1645

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

25.6

347

1959

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

25.5

617

4176

R5110, ,

SPAT

2.4

25.5

184

809

A08AA10

ATC

sibutramine; oral

25.5

25.3

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.1

25.0

107

H02AB04

ATC

methylprednisolone; systemic

2.1

25.0

270

1403

D07AC01

ATC

betamethasone; topical

1.7

24.8

636

4368

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

24.8

205

956

Z3229

NOMESCO Finland

Other healthcare associate professional

2.5

24.7

166

705

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.1

24.7

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

6.9

24.7

L03.3

ICD-10 Finland

Cellulitis of trunk

7.6

24.7

S29

ICPC

Skin symptom/complaint other

1.9

24.5

378

2227

D07BC01

ATC

betamethasone and antiseptics; topical

2.2

24.4

232

1146

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.4

24.4

183

818

QDB10, ,

SPAT

3.8

24.4

203

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

5.0

24.3

106

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

24.2

428

2630

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

24.2

754

5455

J20

ICD-10 Finland

Acute bronchitis

2.3

24.1

200

934

H03AA01

ATC

levothyroxine sodium; systemic

1.9

24.1

418

2555

R60.1

ICD-10 Finland

Generalized oedema

8.5

24.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

23.9

146

593

N03AX11

ATC

topiramate; oral

4.2

23.8

157

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.4

23.7

171

751

E66.1

ICD-10 Finland

Drug-induced obesity

126.9

23.6

S01

ICPC

Pain/tenderness of skin

3.0

23.5

109

382

H3601, E113,

ICD-10 Finland

6.1

23.5

D09AB01

ATC

zinc bandage without supplements; topical

4.6

23.5

125

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

7.9

23.4

R03AC12

ATC

salmeterol; inhalant

3.2

23.4

308

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

5.4

23.3

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.6

23.3

Z2446

NOMESCO Finland

Social worker

2.7

23.2

128

493

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

23.2

424

2628

SPAT1151

SPAT

Treatment of major wounds

6.5

23.1

C02EA02, ,

ATC

3.5

23.0

245

A04

ICPC

Weakness/tiredness general

2.0

23.0

284

1547

XG460

NOMESCO Finland

Short time oxymetry

5.6

23.0

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.0

22.8

100

E87.6

ICD-10 Finland

Hypokalaemia

3.3

22.8

282

SPAT1125

SPAT

Stoma care and guidance

5.6

22.8

S17

ICPC

Abrasion/scratch/blister

4.5

22.8

128

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

22.8

449

2845

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.6

22.8

144

594

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.4

22.7

163

713

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.5

22.7

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

22.6

498

3260

N05AA01

ATC

chlorpromazine; systemic, rectal

5.6

22.5

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

45.7

22.4

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

4.2

22.3

143

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

27.7

22.3

A41.8

ICD-10 Finland

Other specified sepsis

4.7

22.3

114

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

22.2

120

457

R03BB01

ATC

ipratropium bromide; inhalant

3.5

22.2

226

J01DA09

ATC

[U] cefadroxil

1.8

22.2

451

2880

L03

ICPC

Low back symptom/complaint

1.7

22.2

517

3434

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.7

22.0

111

C08CA02

ATC

felodipine; oral

2.3

22.0

178

821

WVA30, ,

SPAT

2.5

21.9

144

605

R28

ICPC

Limited function/disability (R)

5.4

21.9

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.6

21.9

135

550

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

21.9

271

1476

N05AF05

ATC

zuclopenthixol; systemic

6.8

21.7

A10BX09

ATC

[U] dapagliflozin

7.0

21.7

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

7.0

21.7

J01CE02

ATC

phenoxymethylpenicillin; oral

1.7

21.6

1096

8904

L73.2

ICD-10 Finland

Hidradenitis suppurativa

6.2

21.6

3055, ,

Kela drug reimbursment

8.8

21.6

N30.0

ICD-10 Finland

Acute cystitis

2.0

21.5

290

1625

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.4

21.5

246

ZXE00

NOMESCO Finland

One hour or less

1.7

21.4

637

4510

M79.7

ICD-10 Finland

Fibromyalgia

3.4

21.4

232

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.5

21.4

118

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

21.3

480

3152

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

3.5

21.3

218

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

7.1

21.2

C08DB01

ATC

diltiazem; oral

3.0

21.2

332

F32.1

ICD-10 Finland

Moderate depressive episode

2.7

21.2

116

445

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.5

21.2

146

627

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

21.2

1186

9868

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.5

21.1

115

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.8

21.1

405

2539

N07BB01

ATC

disulfiram; oral

3.0

21.1

328

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

28.5

21.0

SPAT1251

SPAT

Organisation of medication

3.5

21.0

220

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.1

20.9

220

1127

L03.9

ICD-10 Finland

Cellulitis, unspecified

4.4

20.9

120

QDA10

NOMESCO Finland

Incision of skin of lower limb

7.8

20.8

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.6

20.7

125

504

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

20.5

614

4342

C03BA11

ATC

indapamide; oral

3.8

20.5

166

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

7.9

20.4

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

6.8

20.4

UKC02

NOMESCO Finland

Cystoscopy

1.9

20.3

279

1571

P01AB01

ATC

metronidazole; oral, rectal

1.6

20.2

671

4865

K92.1

ICD-10 Finland

Melaena

2.8

20.2

107

404

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

20.0

141

611

A01

ICPC

Pain general/multiple sites

2.1

20.0

202

1018

L90

ICPC

Osteoarthrosis of knee

2.4

20.0

142

618

A02BC01

ATC

omeprazole; systemic

1.7

20.0

449

2938

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

19.9

317

1873

T92

ICPC

Gout

4.0

19.8

147

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.8

19.8

N30.9

ICD-10 Finland

Cystitis, unspecified

2.6

19.8

124

509

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

19.8

401

2548

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.9

19.7

157

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

19.6

138

598

GX1P5

NOMESCO Finland

Nocturnal CO2 monitoring

106.3

19.6

AA40B, ,

NOMESCO Finland

19.7

19.5

SPAT1252

SPAT

Overall medication plan or its review

2.5

19.5

129

543

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.9

19.5

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.5

19.5

196

Z08

ICPC

Social welfare problem

5.5

19.4

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.3

19.3

152

692

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

19.3

217

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.4

19.3

111

SPAT1054

SPAT

Examination of peripheral nervous system

4.6

19.2

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

19.2

333

2018

E000006, ,

ATC

2.5

19.2

130

554

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.4

19.1

208

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

19.0

227

1217

JN4AD

NOMESCO Finland

Body CT examination

2.0

19.0

226

1210

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

18.9

604

4320

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.7

18.9

171

QXB99, ,

SPAT

3.4

18.9

215

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

3.4

18.9

210

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

18.8

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

18.5

406

2631

R03AC13

ATC

formoterol; inhalant

2.7

18.4

105

411

OAB43, ,

SPAT

0.5

18.4

166

3134

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

18.4

486

3307

C09DA01

ATC

losartan and diuretics; oral

2.0

18.3

205

1073

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.0

18.3

133

N05AB01

ATC

dixyrazine; systemic

5.4

18.3

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.1

18.3

201

1045

R04.0

ICD-10 Finland

Epistaxis

2.3

18.2

145

663

XF640, ,

NOMESCO Finland

3.7

18.2

161

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

18.2

157

743

B01AB04

ATC

dalteparin; parenteral

2.8

18.1

357

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

18.0

162

779

D01AE15

ATC

terbinafine; topical

2.3

18.0

137

614

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

18.0

144

660

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.5

17.9

177

L15

ICPC

Knee symptom/complaint

1.7

17.9

442

2951

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.0

17.9

206

1089

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

17.8

160

769

SPAT1241

SPAT

Extensive assessment of psychosocial situation

7.0

17.8

R32

ICD-10 Finland

Unspecified urinary incontinence

3.6

17.8

173

RK323, ,

NOMESCO Finland

18.3

17.8

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.2

17.7

234

L60.0

ICD-10 Finland

Ingrowing nail

2.7

17.7

384

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

17.7

344

GBB00

NOMESCO Finland

Tracheostomy

5.5

17.6

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

5.8

17.6

K81.9

ICD-10 Finland

Cholecystitis, unspecified

6.4

17.6

A10AE06

ATC

insulin degludec; parenteral

3.1

17.6

251

R06AE07

ATC

cetirizine; oral

1.6

17.6

696

5217

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

5.3

17.5

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.2

17.5

220

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

17.5

581

4176

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.1

17.5

174

871

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.6

17.5

GD2SN

NOMESCO Finland

Lung ventilation SPECT

7.1

17.4

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.0

17.4

274

N06AA04

ATC

clomipramine; systemic

4.4

17.4

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.4

17.3

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

17.3

125

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.2

17.3

227

E000003, ,

ATC

2.8

17.3

314

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.3

17.2

SPAT1284

SPAT

Extensive health certificate

3.6

17.2

158

W19

ICD-10 Finland

Unspecified fall

2.1

17.2

177

898

N02AC04

ATC

dextropropoxyphene; oral

3.2

17.1

223

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

4.5

17.1

N02BF01

ATC

gabapentin; oral

2.0

17.0

201

1072

SPAT1377

SPAT

Polysomnography

3.0

17.0

256

XA421

NOMESCO Finland

Nocturnal polygraphy

13.4

17.0

R03AK11

ATC

formoterol and fluticasone; inhalant

3.4

16.9

179

LCA06

NOMESCO Finland

Biopsy of endometrium

2.0

16.9

202

1082

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

16.8

186

969

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

16.8

451

3071

B80

ICPC

Iron deficiency anaemia

3.6

16.8

156

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.9

16.7

223

1239

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

3.0

16.7

264

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.5

16.7

ZZA00

NOMESCO Finland

Split skin graft

3.3

16.7

201

S80.0

ICD-10 Finland

Contusion of knee

2.2

16.7

140

655

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.6

16.6

152

A10BD03

ATC

metformin and rosiglitazone; systemic

4.6

16.6

R4180

NOMESCO Finland

Podiatric therapy

4.7

16.6

M09AX01

ATC

hyaluronic acid; parenteral

2.7

16.6

338

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.7

16.4

328

Z3231

NOMESCO Finland

Registered nurse

1.7

16.4

430

2906

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

16.4

318

1983

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.3

16.4

193

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.5

16.3

159

UJF32

NOMESCO Finland

Coloscopy

1.6

16.3

444

3031

A07AA02

ATC

nystatin; oral

2.5

16.3

105

437

D07AC13

ATC

mometasone; topical

1.6

16.2

481

3354

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.2

16.1

105

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.5

16.1

102

421

EBA10

NOMESCO Finland

Operative extraction of tooth

2.0

16.1

188

998

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

16.0

130

599

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.8

15.9

133

N05BA12

ATC

alprazolam; oral

2.0

15.8

180

946

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.2

15.8

D75.1

ICD-10 Finland

Secondary polycythaemia

6.7

15.8

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

4.9

15.7

SPAT1276

SPAT

Outlining of treatment with patient or their family members

3.7

15.7

139

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.7

15.7

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

2.9

15.7

268

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.7

15.6

337

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.8

15.6

291

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

3.5

15.6

154

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.5

15.6

103

434

M02AA07

ATC

piroxicam; topical

1.6

15.5

581

4265

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

15.5

345

2230

-56

ICPC

Dressing/pressure/compress/tamponade

4.4

15.5

SPAT1051

SPAT

Guidance regarding sleep disorders

4.4

15.5

N05AF01

ATC

flupentixol; systemic

4.1

15.5

104

YHMAS, ,

NOMESCO Finland

6.5

15.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.8

15.4

299

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.6

15.4

141

TK800

NOMESCO Finland

Hemodialysis

3.8

15.4

127

S22

ICPC

Nail symptom/complaint

2.2

15.3

128

597

N06AX26

ATC

vortioxetine; oral

2.3

15.3

126

584

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.6

15.3

370

P28

ICPC

Limited function/disability (P)

6.0

15.3

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

15.2

471

3306

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

15.2

144

707

L16

ICPC

Ankle symptom/complaint

1.9

15.2

208

1165

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.5

15.1

403

ZXD00

NOMESCO Finland

Emergency procedure

3.1

15.0

209

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

15.0

386

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

15.0

236

F20.0

ICD-10 Finland

Paranoid schizophrenia

6.8

14.9

N06AG02

ATC

moclobemide; oral

2.7

14.9

322

KGH10

NOMESCO Finland

Operation for phimosis

3.3

14.8

169

SPAT1058

SPAT

PEF monitoring instruction

2.1

14.8

138

673

AA43B, ,

NOMESCO Finland

57.2

14.8

N05AE04

ATC

ziprasidone; systemic

11.4

14.8

N06AA12

ATC

doxepin; systemic

2.5

14.8

401

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.7

14.7

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

14.7

437

3034

F31

ICD-10 Finland

Bipolar affective disorder

5.3

14.7

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

14.6

398

2706

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.9

14.6

234

AN1

Coronary angiography

2.0

14.6

176

944

A10BB07

ATC

glipizide; oral

6.4

14.6

D07XC01

ATC

betamethasone; topical

1.9

14.6

208

1180

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

14.5

372

2490

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

14.5

250

1502

SPAT1307

SPAT

Psychosocial counselling and guidance

2.7

14.5

297

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.9

14.5

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.9

14.4

252

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.7

14.4

128

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

14.4

128

ZY010

NOMESCO Finland

Hospital outpatient

2.5

14.4

369

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.6

14.4

351

P06

ICPC

Sleep disturbance

1.8

14.4

215

1238

M48.0

ICD-10 Finland

Spinal stenosis

1.8

14.3

214

1231

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

14.3

242

D07AA02

ATC

hydrocortisone; topical

1.9

14.3

211

1209

N05BA02

ATC

chlordiazepoxide; systemic

3.3

14.3

168

IGY02, ,

SPAT

4.4

14.3

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

14.3

163

857

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.9

14.3

248

J98.6

ICD-10 Finland

Disorders of diaphragm

13.5

14.2

SGA01

NOMESCO Finland

Emergency treatment

1.7

14.1

268

1655

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

14.1

477

3410

A69

ICPC

General and Unspecified, Other reason for encounter NEC

3.1

14.0

196

P01

ICPC

Feeling anxious/nervous/tense

2.0

14.0

169

906

B01AB10

ATC

tinzaparin; parenteral

1.9

14.0

197

1112

M01AX17

ATC

nimesulide; oral

1.6

14.0

392

2680

G04BD04

ATC

oxybutynin; oral, transdermal

2.4

14.0

399

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

14.0

122

580

R10.0

ICD-10 Finland

Acute abdomen

3.0

13.9

208

WX213

NOMESCO Finland

Lower leg blockade

6.1

13.9

WVA20, ,

SPAT

2.7

13.9

298

XA420

NOMESCO Finland

Extensive sleep examination

5.1

13.9

WX290

NOMESCO Finland

Other blockage of nerve

1.5

13.9

739

5813

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

13.9

142

718

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.5

13.8

370

R05

ICPC

Cough

1.6

13.8

406

2808

S20

ICPC

Corn/callosity

3.5

13.8

142

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

13.8

108

491

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

13.8

339

2244

A29

ICPC

General symptom/complaint other

1.8

13.7

231

1377

D05AX52

ATC

calcipotriol, combinations; topical

2.4

13.7

415

R03AC18

ATC

indacaterol; inhalant

6.5

13.7

R33

ICD-10 Finland

Retention of urine

2.1

13.7

131

646

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

13.7

733

5768

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.0

13.6

210

K93

ICPC

Pulmonary embolism

5.0

13.6

N05BE01

ATC

buspirone; oral

2.9

13.6

216

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.1

13.6

B37.2

ICD-10 Finland

Candidiasis of skin and nail

5.5

13.6

D07AB08

ATC

desonide; topical

1.9

13.5

174

953

D11

ICPC

Diarrhoea

1.9

13.5

187

1049

EBA30

NOMESCO Finland

Extraction of root of tooth

2.2

13.5

112

521

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

4.2

13.5

E11.01

ICD-10 Finland

Non-insulin dependent diabetes diabetic coma with hyperglycaemia

34.3

13.5

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.7

13.5

285

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.2

13.5

117

555

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.3

13.5

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

13.4

132

657

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.6

13.4

297

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.0

13.4

212

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.0

13.4

196

N06AB05

ATC

paroxetine; oral

2.3

13.4

105

477

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.5

13.4

130

N06AX05

ATC

trazodone; oral

3.2

13.4

170

J01CA04

ATC

amoxicillin; systemic

1.6

13.4

1295

11490

ACC51

NOMESCO Finland

Release of median nerve

2.1

13.3

139

707

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.5

13.3

OAB74, ,

SPAT

4.8

13.3

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.6

13.3

293

R52.9

ICD-10 Finland

Pain, unspecified

1.9

13.3

178

989

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.5

13.3

353

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.6

13.3

299

C07AG02

ATC

carvedilol; oral

2.3

13.2

102

460

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

13.2

159

851

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

5.8

13.2

N03AF02

ATC

oxcarbazepine; oral

2.9

13.2

214

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

5.2

13.2

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

13.1

218

1294

A03

ICPC

Fever

1.7

13.1

261

1631

R11

ICD-10 Finland

Nausea and vomiting

2.0

13.1

147

768

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.6

13.1

F32

ICD-10 Finland

Depressive episode

2.4

13.1

380

A10AB04

ATC

insulin lispro; parenteral

3.0

13.1

199

K02.1

ICD-10 Finland

Caries of dentine

1.5

13.0

920

7616

M02AA10

ATC

ketoprofen; topical

1.7

13.0

263

1652

BEF00, ,

SPAT

5.1

12.9

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

12.9

206

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.9

12.9

182

1028

OAA67, ,

SPAT

0.4

12.9

1675

K78

ICPC

Atrial fibrillation/flutter

2.1

12.9

130

654

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

12.8

201

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.8

12.8

246

A01AB09

ATC

miconazole; local oral

2.0

12.8

139

718

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.4

12.7

372

J01XX08

ATC

linezolid; systemic

5.8

12.7

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.9

12.7

208

G04BD12

ATC

mirabegron; oral

1.8

12.7

209

1238

K02.2

ICD-10 Finland

Caries of cementum

2.4

12.6

393

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.3

12.5

1272

C09DA03

ATC

valsartan and diuretics; oral

2.4

12.5

375

I26

ICD-10 Finland

Pulmonary embolism

5.3

12.5

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

12.5

128

647

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

6.2

12.5

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

24.5

12.5

F61

ICD-10 Finland

Mixed and other personality disorders

13.3

12.4

SPAT1060

SPAT

Administration of oxygen

13.3

12.4

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.8

12.4

103

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

4.1

12.4

SPD01

NOMESCO Finland

Mucosa-supported complete denture

4.5

12.4

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.3

12.4

142

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.1

12.3

R52.2

ICD-10 Finland

Other chronic pain

2.5

12.3

316

SPAT1143

SPAT

Partial or complete excision of nail

5.9

12.3

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.5

12.3

335

Z3226

NOMESCO Finland

Physiotherapist

1.7

12.2

279

1806

C07AB03

ATC

atenolol; systemic

2.3

12.2

443

RK250, ,

NOMESCO Finland

9.7

12.2

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.8

12.2

229

G72.8

ICD-10 Finland

Other specified myopathies

3.9

12.2

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

12.2

296

1947

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.2

12.1

SPAT1138

SPAT

Guidance concerning bowel function

4.2

12.1

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

3.0

12.1

181

40199

ICD-8 Finland

Essential benign hypertension

4.0

12.0

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

10.1

12.0

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.1

12.0

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.3

11.9

135

SPAT1325

SPAT

Vaccination

1.5

11.9

483

3565

N07BA03

ATC

varenicline; oral

2.3

11.9

416

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.8

11.9

210

K59.0

ICD-10 Finland

Constipation

2.3

11.9

429

R03BA08

ATC

ciclesonide; inhalant

1.9

11.9

149

809

A07AA09

ATC

vancomycin; oral

4.1

11.9

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.9

11.9

199

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

11.9

868

7179

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5.4

11.8

OAB49, ,

SPAT

5.4

11.8

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.3

11.8

141

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.3

11.8

141

R99

ICPC

Respiratory disease other

3.4

11.8

126

WZC30

NOMESCO Finland

Teaching

1.6

11.8

279

1823

R03DC01

ATC

zafirlukast; oral

3.8

11.8

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.4

11.7

367

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

11.7

158

878

SPE90

NOMESCO Finland

Other partial denture

3.2

11.7

152

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

11.7

211

1281

ZXA10

NOMESCO Finland

Bilateral

1.6

11.7

281

1842

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

11.6

420

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

11.6

216

1324

CL2S4, ,

SPAT

3.2

11.6

148

R55

ICD-10 Finland

Syncope and collapse

1.8

11.6

180

1047

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

5.3

11.5

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

11.5

602

4667

F60.8

ICD-10 Finland

Other specific personality disorders

8.7

11.5

SPAT1202

SPAT

Intra-articular injection

2.8

11.5

208

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

10.1

11.5

M01AB51

ATC

indometacin, combinations; oral, rectal

3.1

11.5

154

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.9

11.5

181

K04.1

ICD-10 Finland

Necrosis of pulp

1.8

11.4

183

1074

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.9

11.4

JKA20

NOMESCO Finland

Cholecystectomy

3.0

11.4

171

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.6

11.4

250

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.9

11.3

193

ECB00

NOMESCO Finland

Suture of gingiva

2.6

11.3

262

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

11.3

184

1084

A08AA62

ATC

bupropion and naltrexone; systemic

8.4

11.3

C09BA03

ATC

lisinopril and diuretics; oral

3.2

11.3

140

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

9.0

11.3

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

11.3

167

957

S19

ICPC

Skin injury other

2.5

11.3

293

WX723, ,

SPAT

4.5

11.2

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

3.6

11.2

101

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

4.8

11.2

C07BB07

ATC

bisoprolol and thiazides; systemic

2.5

11.2

276

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

553

894

8.83

307.65

7.7

3.5

6.11

5.11

kpa

54.91

543

870

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

501

765

9.00

307.65

6.8

3.4

4.43

1.71

mmol/l

27.99

442

578

(3009343) pH of Capillary blood

536

873

8.64

307.65

7.7

3.5

7.40

7.42

10.23

490

743

(3003396) Base excess in Arterial blood by calculation

708

1773

6.27

286.96

10.3

8.3

3.76

0.88

mmol/l

46.12

650

1466

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

702

1792

6.11

277.30

10.3

8.3

6.26

5.07

kpa

75.80

686

1725

(3027801) Oxygen [Partial pressure] in Arterial blood

702

1792

6.11

277.30

10.3

8.3

8.89

12.46

kpa

97.41

681

1726

(3019977) pH of Arterial blood

697

1781

6.07

274.67

10.4

8.4

7.40

7.42

12.09

519

980

(3016502) Oxygen saturation in Arterial blood

630

1602

5.77

246.16

9.7

8.8

91.91

95.73

38.46

613

1546

(1616796) Gas panel - Central venous blood

261

297

10.27

215.43

8.5

3.1

—

(3023368) Bacteria identified in Blood by Culture

985

4085

4.54

199.33

7.7

4.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1020

4443

4.44

190.32

5.2

3.1

1536.44

1203.63

ng/l

1.14

892

3824

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

405

924

5.50

173.33

10.1

10.3

26.78

24.24

mmol/l

28.52

396

910

(3027315) Oxygen [Partial pressure] in Blood

218

267

9.27

168.96

9.6

3.4

8.23

8.61

kpa

1.77

213

261

(3013290) Carbon dioxide [Partial pressure] in Blood

218

268

9.23

168.45

9.6

3.4

5.76

4.97

kpa

17.22

213

262

(3012501) Base excess in Blood by calculation

217

268

9.18

167.03

9.6

3.4

4.70

2.35

mmol/l

10.35

180

175

(3022313) Gas panel - Capillary blood

317

603

6.28

164.74

8.2

3.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

591

1946

4.19

157.64

6.0

5.8

1.08

1.02

mmol/l

4.72

549

1801

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

675

2470

3.95

154.37

3.0

1.9

—

(3010421) pH of Blood

255

456

6.44

140.19

9.0

2.9

7.41

0.07

250

450

(3012095) Magnesium [Moles/volume] in Serum or Plasma

656

2499

3.71

138.75

3.2

3.5

0.82

mmol/l

0.08

608

2364

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

371

959

4.71

134.37

11.5

8.4

28.21

24.82

mmol/l

26.77

366

953

(3020682) Albumin/Creatinine [Ratio] in Urine

993

5021

3.49

131.84

5.2

4.0

12.56

7.68

mg/mmol

2.23

653

3054

(3007853) Bacteria identified in Skin by Aerobe culture

502

1670

3.89

128.65

2.5

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

576

2134

3.62

125.12

3.2

2.6

17.16

23.23

22.43

504

1996

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

247

479

5.90

124.34

8.1

3.8

26.61

24.84

mmol/l

11.36

238

444

(3006184) Hemoglobin [Mass/volume] in Capillary blood

209

346

6.78

123.49

4.6

2.1

133.34

130.13

g/l

0.82

180

274

(3004789) Transferrin [Mass/volume] in Serum or Plasma

598

2307

3.51

121.35

3.1

2.5

2.50

2.30

g/l

10.79

521

2142

(3024561) Albumin [Mass/volume] in Serum or Plasma

1158

6646

3.54

120.75

6.3

5.1

32.77

35.86

g/l

62.22

1089

6255

(3032080) INR in Blood by Coagulation assay

1180

6858

3.58

120.38

23.7

14.7

1.31

1.24

inr

4.26

1073

5721

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

809

3771

3.26

119.77

3.2

2.3

4.19

2.79

mg/l

21.95

709

3255

(3017569) Oxygen content in Arterial blood

110

14.14

117.82

3.0

2.5

16.79

16.22

0.56

110

(3012516) Albumin [Mass/volume] in Urine

953

4929

3.23

117.25

4.0

3.4

78.14

41.29

mg/l

3.02

652

3090

(3008152) Bicarbonate [Moles/volume] in Arterial blood

348

950

4.38

116.36

11.5

7.3

28.43

24.45

mmol/l

38.10

339

906

(3009508) Creatinine [Moles/volume] in Urine

974

5171

3.18

113.17

4.0

3.3

7.25

7.55

mmol/l

1.20

783

4387

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

455

1533

3.73

112.81

6.2

3.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

611

2485

3.33

112.42

3.3

2.6

10.12

13.30

umol/l

24.26

536

2321

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

270

623

4.99

111.24

2.6

2.0

2.83

1.60

ug/l

0.49

239

559

(3019309) Folate [Moles/volume] in Red Blood Cells

581

2367

3.25

105.52

2.6

1.7

1401.53

1175.31

nmol/l

5.20

432

1796

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

500

1866

3.42

104.85

2.8

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1014

5703

3.04

102.69

6.9

3.7

35.83

69.07

ng/l

1.27

839

4061

(3026008) Bacteria identified in Urine by Culture

846

4317

2.99

102.37

5.0

3.1

—

(40761536) Microorganisms panel - Urine sediment

367

1147

3.84

100.67

5.8

3.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

398

1343

3.59

97.04

7.3

7.7

12.49

9.35

mmol/l

11.19

388

1296

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

468

1773

3.30

94.59

2.8

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

659

3046

2.95

93.81

2.7

1.7

433.92

37283219.47

pmol/l

3.26

527

2532

(3002032) Base excess in Venous blood by calculation

410

1441

3.46

93.48

5.5

3.4

4.85

1.76

mmol/l

28.57

377

1250

(42870588) Differential panel, method unspecified - Blood

917

5059

2.85

93.08

7.2

6.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1190

7569

3.10

91.72

12.1

7.3

1.19

1.21

mmol/l

26.35

967

6569

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

690

3313

2.87

90.88

2.1

1.8

1.14

1.22

mg/l

0.33

563

2559

(3021447) Carbon dioxide [Partial pressure] in Venous blood

415

1498

3.37

90.36

5.4

3.4

7.17

5.79

kpa

44.23

400

1462

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1105

6801

2.92

89.57

12.6

6.6

1.19

1.21

mmol/l

16.34

1022

6307

(3012544) pH of Venous blood

410

1485

3.35

88.61

5.5

3.5

7.36

7.38

9.73

271

830

(3013826) Glucose [Moles/volume] in Serum or Plasma

1290

8734

3.25

85.98

12.0

5.1

7.49

6.65

mmol/l

23.05

1253

8340

(3026493) Urate [Moles/volume] in Serum or Plasma

753

3918

2.71

83.03

3.5

2.7

408.66

339.10

umol/l

34.16

642

3484

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1204

7934

2.96

82.51

7.2

6.9

10.98

11.62

umol/l

0.80

1134

7607

(3042936) Bacteria identified in Isolate by Culture

499

2114

2.96

81.48

2.9

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

348

1199

3.42

80.89

5.6

3.5

1.20

1.23

mmol/l

9.70

288

1030

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

383

1440

3.17

76.73

2.5

2.3

0.19

0.21

g/l

6.13

348

1355

(3014111) Lactate [Moles/volume] in Serum or Plasma

376

1406

3.17

75.96

11.6

7.9

1.46

1.35

mmol/l

1.02

368

1382

(3019069) Monocytes/Leukocytes in Blood

1087

6976

2.66

75.10

8.5

6.7

8.52

8.91

4.78

1038

6548

(3022096) Basophils/Leukocytes in Blood

1083

6969

2.64

73.87

8.5

6.7

0.56

0.70

15.40

1033

6538

(3006504) Eosinophils/Leukocytes in Blood

1083

6970

2.64

73.83

8.4

6.6

2.55

2.87

5.49

1034

6542

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

173

385

4.91

73.42

1.8

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

251

750

3.77

72.06

2.0

1.5

—

(3013115) Eosinophils [#/volume] in Blood

1169

7856

2.71

72.06

8.8

6.6

0.20

0.19

e9/l

0.85

1051

6868

(3006315) Basophils [#/volume] in Blood

1140

7621

2.63

70.08

8.2

6.4

0.04

e9/l

0.17

1022

6549

(3001604) Monocytes [#/volume] in Blood

1138

7608

2.63

69.84

8.2

6.4

0.66

0.58

e9/l

21.62

1024

6537

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

824

4774

2.46

68.75

3.5

2.6

45.88

78.75

u/l

1.28

754

4436

(3002030) Lymphocytes/Leukocytes in Blood

1086

7133

2.55

68.66

8.5

6.6

22.83

27.79

45.77

1050

6775

(3019198) Lymphocytes [#/volume] in Blood

1147

7755

2.60

67.73

8.3

6.4

1.79

1.93

e9/l

2.69

1041

6831

(3026782) Osmolality of Urine

569

2798

2.58

67.43

3.6

2.9

497.43

528.30

mosm/kgh2o

2.77

510

2457

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

136

266

5.49

66.80

1.7

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

169

399

4.61

66.57

1.7

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

171

409

4.55

66.26

2.2

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

353

1376

3.00

65.47

2.3

2.2

313.57

383.23

nmol/l

8.06

327

1290

(3024354) Oxygen [Partial pressure] in Venous blood

331

1250

3.07

64.89

5.2

2.8

4.79

4.52

kpa

1.61

317

1219

(3000991) Gas panel - Venous blood

342

1320

3.01

64.48

12.4

9.1

—

(3018010) Neutrophils/Leukocytes in Blood

1060

7002

2.46

64.27

8.2

6.4

62.87

57.15

47.51

1029

6706

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

300

1080

3.18

63.79

2.0

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

149

7.01

63.30

7.8

7.0

7.54

6.98

mmol/l

0.89

127

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1018

6736

2.35

59.46

4.8

3.0

121.43

134.93

ug/l

1.29

921

6295

(3002179) Metamyelocytes/Leukocytes in Blood

322

1288

2.87

56.27

4.5

4.4

0.62

0.69

0.25

110

385

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

108

201

5.68

55.86

1.7

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

612

3338

2.33

55.59

3.7

2.6

8.01

5.38

e6/l

4.26

563

3059

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

119

7.29

55.41

1.7

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

103

185

5.87

55.30

1.8

1.7

—

(3021440) Promyelocytes/Leukocytes in Blood

320

1295

2.83

54.59

5.1

4.6

0.06

0.12

1.34

105

349

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

270

1003

3.03

53.81

13.7

10.3

0.58

0.64

1.84

270

997

(3029937) Albumin [Presence] in Urine by Test strip

725

4289

2.24

53.72

6.0

3.9

0.01

0.00

estimate

0.31

348

1485

(3018418) pH of Serum or Plasma

764

4618

2.23

53.65

5.9

4.1

7.40

0.09

583

3342

(3017181) Myelocytes/Leukocytes in Blood

327

1356

2.76

53.13

5.0

4.5

0.96

0.97

0.02

111

410

(3021960) Folate [Moles/volume] in Serum or Plasma

720

4271

2.22

52.73

2.1

1.7

18.71

20.33

nmol/l

2.28

616

3598

(3031040) Bacteria [#/volume] in Urine by Automated count

1260

9411

2.47

51.91

8.0

4.5

800.68

1870.76

e6/l

0.61

129

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

340

4.34

51.22

1.7

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

114

241

5.01

51.10

1.7

1.5

—

(3025159) Blasts/Leukocytes in Blood

316

1315

2.74

50.82

5.3

4.8

0.01

0.12

2.15

326

(3013650) Neutrophils [#/volume] in Blood by Automated count

1176

8563

2.33

50.74

12.1

10.0

5.22

4.02

e9/l

42.82

1062

7468

(3027273) Bicarbonate [Moles/volume] in Venous blood

198

645

3.35

49.04

4.9

3.1

28.51

25.30

mmol/l

12.93

186

623

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

971

6603

2.16

48.87

2.8

2.1

91.52

96.61

pmol/l

2.82

606

3466

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1427

11429

2.94

48.74

11.6

8.4

88.07

78.87

u/l

6.56

1372

10895

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

124

293

4.50

48.52

1.7

1.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

372

1714

2.51

48.39

2.7

2.17

1.80

8.42

316

1549

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

288

4.50

47.79

1.6

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

159

459

3.73

47.36

3.3

3.2

0.39

0.37

iu/ml

0.28

248

(3023183) Ammonium ion [Moles/volume] in Plasma

131

332

4.20

46.79

2.9

3.1

34.64

33.73

umol/l

0.20

121

301

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

792

5069

2.09

45.73

3.4

3.3

32.22

32.50

u/l

0.06

731

4808

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

147

413

3.81

45.50

1.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

7.08

41.30

1.7

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

795

5227

2.01

41.24

3.3

3.7

2.34

2.36

mmol/l

3.48

728

4778

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

960

6753

2.02

41.00

3.6

2.4

70.45

78.69

nmol/l

18.48

872

6133

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

228

894

2.80

40.56

2.6

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

296

1332

2.49

39.83

2.6

2.7

83.57

70.38

e9/l

7.30

228

995

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

198

733

2.94

39.13

6.9

3.5

51.44

48.18

0.98

192

722

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

104

6.47

39.11

1.7

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.74

38.88

1.7

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

665

4171

2.00

38.78

4.3

3.2

0.87

0.42

e6/l

3.35

566

3051

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

264

1142

2.56

38.53

1.7

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

563

3337

2.05

38.41

6.5

4.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

1049

7716

2.00

38.21

5.7

3.8

0.00

estimate

0.33

388

1592

(3035350) Ketones [Presence] in Urine by Test strip

1059

7822

2.00

38.03

5.7

3.8

7.81

4.10

estimate

0.28

398

1625

(3009261) Glucose [Presence] in Urine by Test strip

1062

7870

1.99

37.55

5.7

3.8

2.96

0.21

estimate

0.46

343

1519

(3002582) Erythrocytes [#/volume] in Urine

736

4838

1.95

36.94

4.6

3.3

61.21

66.87

e6/l

0.09

627

3690

(3021589) Normoblasts [#/volume] in Blood

929

6606

1.94

36.76

24.0

11.3

0.00

e9/l

0.42

811

5414

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

258

1131

2.52

36.50

4.8

3.1

184.27

196.95

ng/l

0.22

241

1034

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

158

546

3.10

35.15

2.2

2.3

467.56

412.30

ug/l

0.18

149

515

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

183

692

2.85

34.65

8.2

5.7

2.30

1.58

5.57

176

649

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

712

4701

1.91

34.61

2.9

2.2

185.98

205.68

u/l

0.35

667

4472

(3041096) Erythrocytes [Presence] in Urine by Automated

648

4177

1.91

33.64

5.6

3.3

0.78

0.23

estimate

0.32

337

1262

(3018095) Leukocytes [#/volume] in Urine

791

5483

1.86

32.33

5.4

3.9

110.38

105.60

e6/l

0.05

645

3881

(3007930) Methemoglobin/Hemoglobin.total in Blood

166

628

2.83

31.32

8.9

6.0

0.81

0.88

1.40

160

586

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

107

314

3.58

30.92

2.7

2.5

216.61

112.91

ug/min

0.64

188

(3004119) Hemoglobin [Mass/volume] in Venous blood

219

958

2.48

30.86

4.8

2.9

134.13

129.25

g/l

2.13

207

932

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

337

1783

2.12

30.20

2.6

4.8

242.87

246.26

u/l

0.12

307

1697

(3000494) Fungus identified in Specimen by Culture

348

1871

2.09

29.86

1.6

1.5

—

(3047181) Lactate [Moles/volume] in Blood

131

447

3.10

29.70

11.6

7.2

1.33

1.31

mmol/l

0.08

119

389

(3020630) Protein [Mass/volume] in Serum or Plasma

265

1282

2.27

29.67

2.0

3.0

66.40

66.61

g/l

0.17

236

1185

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

130

446

3.08

29.20

2.7

2.8

2.14

1.52

mg/l

6.81

110

402

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

975

11928

0.55

29.18

46.6

20.7

322.65

332.44

g/l

109.11

967

11871

(3044242) Glucose [Moles/volume] in Arterial blood

5.74

27.97

2.7

2.2

8.89

8.11

mmol/l

0.53

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

243

1170

2.26

27.39

4.4

3.7

117.26

87.61

ng/l

3.65

200

1025

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

142

535

2.81

26.92

3.1

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

133

489

2.87

26.38

2.9

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

136

508

2.83

26.19

2.3

4.1

65.12

58.86

mg/l

0.18

436

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

136

509

2.82

26.09

2.3

4.1

58.72

89.39

mg/l

0.45

438

(3027456) Digoxin [Moles/volume] in Serum or Plasma

265

3.54

25.86

3.9

3.4

0.90

0.83

nmol/l

0.57

218

(3009466) Valproate [Moles/volume] in Serum or Plasma

211

3.83

25.37

6.8

5.4

370.62

359.74

umol/l

0.27

190

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1330

11240

1.98

25.27

5.7

4.4

14.85

14.80

pmol/l

0.27

1228

10367

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

803

5880

1.72

24.88

6.1

3.7

1.51

0.10

estimate

0.46

335

1312

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

273

3.43

24.70

1.7

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

273

3.43

24.70

1.7

1.3

—

(3023419) Bacteria identified in Sputum by Culture

225

3.64

23.86

3.3

2.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

123

459

2.82

23.70

2.4

3.8

1.50

3.97

ratio

1.35

271

(3005322) IgE [Units/volume] in Serum or Plasma

205

977

2.26

23.51

1.5

1.3

192.33

199.03

u/ml

0.07

196

908

(3015736) pH of Urine

828

6187

1.68

23.20

4.5

3.4

6.04

6.21

4.39

462

3507

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

136

544

2.64

22.90

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1193

9868

1.77

22.62

5.3

3.3

61.58

49.67

u/l

5.48

1104

9318

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

160

699

2.43

22.39

1.4

1.8

1.77

1.53

g/l

2.12

134

613

(3000012) Reticulocyte production index

211

3.57

21.57

1.9

2.0

1.12

0.90

1.81

141

(3004588) Protein electrophoresis panel - Serum or Plasma

212

1062

2.14

21.41

2.1

2.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1592

0.24

21.33

2.0

2.1

3.94

3.50

ratio

1.04

1274

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

220

3.43

20.25

6.4

7.5

12.05

11.89

mg/l

0.11

209

(3018572) Chloride [Moles/volume] in Blood

319

3.00

20.25

11.3

8.6

103.00

105.24

mmol/l

4.60

281

(3039000) Anion gap in Blood by calculation

319

3.00

20.25

11.3

8.6

9.90

11.33

mmol/l

2.81

281

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

294

1712

1.87

19.27

2.4

1.9

1.50

1.53

0.24

247

1486

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1278

10973

1.75

19.06

6.1

4.3

22.49

11.70

mm/h

57.79

1184

10270

(3005719) IgG [Mass/volume] in Serum or Plasma

220

1188

1.98

18.00

2.9

10.65

10.72

g/l

0.07

195

1095

(3028026) IgM [Mass/volume] in Serum or Plasma

181

925

2.08

17.22

2.2

1.9

1.18

1.36

g/l

0.71

166

850

(3027923) C peptide [Moles/volume] in Serum or Plasma

4.68

16.85

1.1

1.5

1.92

1.22

nmol/l

2.27

(3037522) Nuclear Ab [Titer] in Serum

328

2052

1.75

16.75

1.4

1.3

483.17

497.77

titre

0.07

457

(40768797) Stomach Pathology biopsy report

340

2150

1.73

16.71

1.3

1.2

—

(3004451) EKG impression Narrative

4.45

16.66

1.2

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

445

3027

1.65

16.60

3.1

3.0

2.49

2.45

mmol/l

9.20

396

2760

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

293

2.86

16.54

1.7

1.5

1.45

0.84

nmol/l

3.30

251

(3004809) Band form neutrophils/Leukocytes in Blood

229

3.10

16.40

2.2

4.3

0.95

1.64

1.40

212

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.66

16.38

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.66

16.38

1.5

1.4

—

(3017732) Neutrophils [#/volume] in Blood

311

1931

1.75

16.26

3.9

3.3

5.17

4.74

e9/l

0.58

264

1687

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

265

2.92

15.99

1.4

1.2

92.73

413.33

titre

0.97

(21494755) Public health laboratory ask at order entry panel

1286

0.27

15.71

1.5

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.27

15.49

8.2

3.0

8.98

10.24

kpa

1.86

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.27

15.49

8.2

3.0

6.95

4.69

kpa

4.51

(44790048) Parainfluenza type 2 nucleic acid detection

195

3.21

15.44

1.7

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

195

3.21

15.44

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

195

3.21

15.44

1.7

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

195

3.21

15.44

1.7

1.5

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1171

0.25

15.18

1.4

1.8

3.01

3.53

mmol/l

1.55

840

(4146454) Self-monitoring of blood glucose

138

3.63

15.10

3.2

2.7

—

(3025941) Bacteria identified in Stool by Culture

149

743

2.11

15.09

1.4

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

120

3.83

15.00

1.4

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.86

14.99

3.7

4.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1497

13746

2.04

14.79

11.8

6.1

46.04

39.08

mmol/mol

82.19

1411

12891

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

218

1251

1.86

14.73

3.0

2.4

4.44

7.98

ug/l

4.17

177

1128

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

101

433

2.42

14.69

1.4

1.7

0.26

0.24

g/l

1.55

413

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

273

2.75

14.04

1.3

22.68

27.81

u/l

0.28

232

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

131

3.58

13.96

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

131

3.58

13.96

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

131

3.58

13.96

1.4

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

102

452

2.34

13.79

1.4

1.7

1.30

1.19

g/l

3.21

430

(3024139) IgG subclass 3 [Mass/volume] in Serum

142

3.45

13.76

1.4

1.3

0.30

0.38

g/l

0.96

(3028192) IgG subclass 2 [Mass/volume] in Serum

142

3.45

13.76

1.4

1.3

2.61

3.01

g/l

0.69

100

(3027135) IgG subclass 1 [Mass/volume] in Serum

142

3.45

13.76

1.4

1.3

7.26

6.86

g/l

0.20

101

(3004775) Volume in Urine collected for unspecified duration

100

3.97

13.73

2.0

2.4

809.83

659.03

0.84

(3042631) Mycobacterium sp identified in Specimen

210

2.98

13.65

3.1

2.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

167

902

1.95

13.54

2.9

3.8

4.16

4.48

pmol/l

3.81

145

805

(4062490) Immunoglobulin typing, IgG

144

3.40

13.47

1.5

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

400

2.40

13.44

1.0

1.2

66.00

81.62

titre

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

275

1741

1.70

13.19

2.7

6.78

7.85

umol/l

0.39

217

1555

(3035637) Corticotropin [Mass/volume] in Plasma

162

3.22

13.08

1.6

1.5

20.86

31.96

ng/l

0.85

162

(3037756) Immunofixation for Serum or Plasma

344

2.49

13.00

1.3

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

330

2201

1.63

12.91

1.8

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

149

3.29

12.78

1.6

1.8

—

(3016750) Collection duration of Urine

4.24

12.73

2.1

2.3

476.06

502.62

min

0.82

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1450

13292

1.80

12.72

7.4

5.4

2.00

1.94

mu/l

0.74

1349

12323

(3014271) Vancomycin [Susceptibility]

4.81

12.62

3.6

2.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

120

590

2.12

12.61

1.9

1.7

0.30

0.37

mg/l

0.68

292

(3018677) aPTT in Platelet poor plasma by Coagulation assay

342

2316

1.60

12.53

2.5

2.0

30.90

29.38

3.82

332

2249

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

113

549

2.14

12.24

3.1

2.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

102

476

2.22

12.22

1.6

1.5

279.29

287.46

ug/g

0.14

291

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.80

12.14

2.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

414

2950

1.54

12.10

6.4

3.8

178.71

403.71

ng/l

2.13

355

2312

(3006571) Granulocytes/Leukocytes in Synovial fluid

176

3.02

12.01

1.7

1.6

72.37

59.51

1.35

115

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

163

3.07

11.67

1.6

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

196

2.87

11.61

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

8.96

11.26

4.1

1.6

5.52

7.94

mmol/l

1.09

(3003329) Lymphocytes/Leukocytes in Synovial fluid

125

3.34

11.26

1.7

1.4

20.78

31.86

1.10

(3025468) Yersinia sp identified in Specimen by Organism specific culture

173

2.95

11.13

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

173

2.95

11.13

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

174

2.93

11.02

1.7

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

437

2.20

10.97

1.6

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

238

1521

1.66

10.90

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1515

14184

1.91

10.89

42.8

15.8

27.23

24.11

mg/l

3.90

1463

11615

(3020911) Cortisol [Moles/time] in 24 hour Urine

5.17

10.80

1.4

1.8

64.30

723.35

nmol/24h

0.51

(3024891) Influenza virus A+B Ag [Presence] in Specimen

375

2.28

10.76

1.4

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.46

10.74

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.46

10.74

1.6

1.4

—

(3011985) Renin [Units/volume] in Plasma

212

2.70

10.58

1.3

108.07

54.85

mu/l

0.65

192

(3006653) Thiamine [Moles/volume] in Blood

4.03

10.51

1.3

1.2

145.90

141.05

nmol/l

0.16

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

126

676

1.94

10.41

2.0

36.77

40.10

u/l

0.99

109

597

(3020491) Glucose [Moles/volume] in Blood

3.56

10.34

3.0

1.8

6.85

6.83

mmol/l

0.01

(3003181) Sodium [Moles/volume] in Urine

293

2.41

10.31

1.5

1.3

62.07

59.93

mmol/l

0.11

242

(3017354) Segmented neutrophils/Leukocytes in Blood

149

3.01

10.19

2.4

4.6

64.14

54.79

2.80

135

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

424

2.16

10.16

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

196

2.71

9.92

1.3

381.43

324.75

pmol/l

0.40

172

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

448

3359

1.46

9.92

1.4

1.3

2.03

1.69

u/ml

0.18

152

929

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.11

9.71

1.9

3.2

95.42

117.56

umol/l

0.18

(3008757) Leukocyte morphology finding [Identifier] in Blood

143

2.99

9.65

2.1

4.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

182

2.74

9.62

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

182

2.74

9.62

1.7

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

242

2.49

9.51

1.4

1.6

0.83

0.85

g/l

0.03

187

(3019225) pH of Specimen

214

1387

1.62

9.22

5.7

4.3

7.37

7.35

0.70

167

1005

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

181

2.70

9.17

1.7

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

986

8555

1.38

9.07

3.6

2.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

394

2931

1.45

8.96

1.8

1.5

3.12

2.47

g/l

5.74

269

1826

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.74

8.90

1.6

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.74

8.90

1.6

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.74

8.90

1.6

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.74

8.90

1.6

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

113

3.14

8.82

1.5

1.4

38.17

19.40

u/ml

—

(3008295) Osmolality of Serum or Plasma

169

2.71

8.68

1.2

1.3

280.90

276.46

mosm/kgh2o

0.52

131

(3028707) Methadone [Presence] in Urine by Screen method

164

2.73

8.61

3.2

2.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

417

2.04

8.29

2.1

2.2

12.54

11.70

mg/l

0.33

386

(3045424) Erythrocytes [Presence] in Urine

126

728

1.79

8.28

2.5

2.1

0.00

1.15

estimate

0.50

218

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

101

547

1.90

8.15

2.6

2.8

0.87

1.27

g/l

0.49

473

(3037121) Protein [Mass/volume] in Urine

519

1.92

8.12

2.9

3.7

244.19

298.78

mg/l

0.39

220

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

262

1833

1.51

8.03

1.7

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

336

2.13

7.90

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.97

7.89

1.6

2.0

—

(3012441) Differential panel - Pleural fluid

146

2.71

7.60

1.3

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

3.13

7.57

2.4

1.4

12.63

13.20

u/l

0.21

(3020191) Ethanol [Moles/volume] in Serum or Plasma

124

2.86

7.56

1.6

1.4

1.15

1.20

promille

0.06

100

(3022145) Colonoscopy Study observation

256

1806

1.49

7.52

1.4

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

357

2.06

7.48

1.3

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

314

0.16

7.48

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

588

1.82

7.36

2.1

2.8

3.14

2.88

g/l

2.05

536

(40758558) Short blood count panel - Blood

560

4552

1.35

7.29

9.3

6.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

216

2.36

7.27

1.0

1.1

1.59

1.52

g/l

0.76

198

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

801

6870

1.32

7.19

3.5

2.8

—

estimate

—

(40768443) Skin Pathology biopsy report

114

668

1.76

7.16

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

187

2.45

7.13

1.2

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

134

2.72

7.11

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1537

14683

1.77

7.11

50.2

18.5

139.70

139.72

mmol/l

0.11

1514

14415

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.79

7.09

1.6

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.79

7.09

1.6

2.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

141

2.66

6.99

4.2

2.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1539

14715

1.77

6.99

50.2

18.7

4.01

3.97

mmol/l

6.49

1516

14421

(3044640) Blood type and Crossmatch panel - Blood

576

4727

1.34

6.97

3.1

2.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

622

1.77

6.91

2.1

2.7

4.14

3.68

g/l

2.13

570

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

190

2.41

6.90

1.3

0.17

0.28

nmol/l

0.60

151

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

623

1.77

6.88

2.1

2.7

4.47

4.18

g/l

2.81

571

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

623

1.77

6.88

2.1

2.7

8.10

7.20

g/l

7.52

570

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

341

2.04

6.88

1.6

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.13

6.60

1.3

1.6

8.24

6.56

u/l

0.24

(3012565) Volume of 24 hour Urine

3.47

6.57

1.7

2.5

1424.71

2044.47

2.30

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

217

3013

0.68

6.57

2.8

3.2

0.59

0.75

ug/l

2.82

142

1912

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

165

2.46

6.46

2.8

2.4

32.36

21.27

mg/l

0.59

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

275

2.11

6.40

1.7

2.0

6243.57

2817.95

u/l

0.30

108

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

3.19

6.30

1.8

2.03

4.47

nmol/l

0.45

(3018851) Theophylline [Moles/volume] in Serum or Plasma

9.29

6.29

1.8

2.2

47.17

54.23

umol/l

0.19

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

7.05

6.22

1.6

2.3

1.17

1.21

mmol/l

0.80

(3020876) Protein [Mass/time] in 24 hour Urine

175

2.38

6.17

2.1

2.4

0.94

1.24

g/24h

0.34

107

(1001926) Buprenorphine [Presence] in Urine by Screen method

294

2.04

6.10

2.7

1.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

189

2.31

6.07

1.2

1.3

—

nmol/l

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

241

2.15

6.05

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

469

3808

1.32

5.92

5.5

4.1

83.86

90.15

5.23

454

3727

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

124

2.61

5.90

1.1

536.00

128.75

titre

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

5.04

5.87

1.2

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

3.06

5.65

1.3

1.8

1.61

2.93

u/field

0.84

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

545

1.73

5.61

2.1

2.8

10.32

10.35

g/l

0.02

490

(40768806) Pleura Pathology biopsy report

141

2.44

5.48

1.6

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

315

3997

0.74

5.47

3.9

4.4

21.54

0.00

118

1914

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

242

1796

1.41

5.38

6.2

4.9

29.16

32.40

5.84

174

1186

(3023199) Leukocytes [#/volume] in Pleural fluid

169

2.28

5.26

1.4

4311.10

1570.23

e6/l

0.80

110

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.95

5.22

2.6

2.5

14.29

18.64

umol/l

0.66

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

120

2.53

5.22

1.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

408

1.80

5.14

1.5

1.7

451.42

296.01

mu/l

1.07

373

(40757373) Influenza virus identified in Isolate

4.87

5.12

1.5

1.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

470

1.74

5.05

2.2

2.7

0.00

0.02

g/l

1.14

421

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

459

1.73

4.91

2.1

2.7

0.00

g/l

-0.00

400

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

529

1.68

4.87

1.4

1.7

13.29

14.81

u/ml

—

134

(3028308) Erythrocytes [#/volume] in Pleural fluid

143

2.33

4.86

1.4

22061.61

77294.85

e6/l

0.59

(3009214) Lutropin [Units/volume] in Serum or Plasma

343

1.84

4.80

1.3

10.30

9.73

u/l

0.13

278

(3042517) Benzodiazepines panel - Urine

11.48

4.78

5.6

1.1

—

(3045414) Leukocytes [Presence] in Urine

196

1432

1.42

4.76

2.6

2.1

0.00

0.02

estimate

0.78

289

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.69

4.75

7.7

1.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

273

1.93

4.72

3.8

2.7

—

(3044927) Protein electrophoresis panel - Urine

165

2.21

4.67

1.3

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

303

1.88

4.65

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

241

1.98

4.57

1.0

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

425

1.73

4.51

2.2

2.8

0.00

g/l

-0.00

399

(3016879) Cocaine [Presence] in Urine

358

1.79

4.49

2.8

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

718

0.49

4.47

1.7

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

237

1.97

4.42

1.0

1.1

16.50

96.37

iu/ml

1.04

(3000764) Benzodiazepines [Presence] in Urine

384

1.75

4.35

2.8

2.0

—

(3024263) Appearance of Synovial fluid

2.90

4.34

1.2

1.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

138

2.27

4.33

2.5

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

127

2.31

4.21

1.1

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.27

4.14

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

5.27

4.14

1.3

1.2

115.09

61.40

ng/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

216

1.97

4.08

2.0

1.5

—

(3049717) Cytology report of Urine Cyto stain

574

1.58

3.99

2.0

2.7

—

(3027008) Opiates [Presence] in Urine

387

1.71

3.98

2.8

2.0

—

(44806420) Estimation of glomerular filtration rate

170

2.08

3.97

2.2

2.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

403

1.69

3.95

1.4

1.7

18269.73

12708.57

e6/l

0.59

287

(3028300) Cannabinoids [Presence] in Urine

388

1.70

3.95

3.0

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

236

1839

1.33

3.85

2.5

2.4

185.86

123.19

ug/g

1.78

187

1482

(3020650) Glucose [Presence] in Urine

3.08

3.81

2.6

1.5

0.00

estimate

-0.00

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

12.04

3.76

1.2

1.0

—

mmol/l

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

223

1.91

3.75

1.0

1.1

123.35

115.84

0.66

205

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.93

3.74

1.9

2.0

4061.00

34055.00

e6/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.02

3.69

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

155

2.09

3.68

1.7

2.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.39

3.65

1.4

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1291

0.66

3.64

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

295

2389

1.29

3.62

4.0

3.0

5.97

2.12

e6/l

3.77

164

1155

(3005532) Lymphocytes/Leukocytes in Pleural fluid

2.96

3.57

1.5

57.20

64.07

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

206

1.92

3.55

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1450

13955

1.34

3.52

7.6

5.1

6.73

5.91

mmol/l

55.84

1310

12876

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

159

2.03

3.46

3.8

4.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.78

3.42

1.1

2.2

23.80

161.41

ug/l

0.47

(3023420) DNA double strand Ab [Units/volume] in Serum

646

1.50

3.40

2.0

1.9

7.22

7.95

iu/ml

0.11

154

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.67

3.40

1.1

1.2

375.59

214.90

iu/ml

0.61

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.77

3.39

1.2

1.1

—

(4198724) Urine methamphetamine measurement

3.11

3.37

1.7

1.4

—

(3027944) Amphetamines [Presence] in Urine

383

1.64

3.36

3.0

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

121

2.17

3.33

1.3

—

(4195642) Thrombophilia screening test

211

1.87

3.32

1.1

1.2

—

(4015189) Microbial culture of sputum

3.44

3.31

3.4

2.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

527

0.50

3.22

1.1

1.2

1.40

1.54

g/l

1.62

527

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.29

3.20

1.4

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.82

3.09

2.9

2.2

—

(40761511) CBC panel - Blood by Automated count

1507

14634

1.38

3.06

37.0

14.2

—

(3045788) Cell count panel - Pleural fluid

146

2.00

3.06

1.3

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

7.52

3.05

1.0

1.8

391.10

653.21

nmol/l

—

(3004616) Nuclear Ab [Presence] in Serum

189

1.87

3.02

1.3

1.2

—

(4281824) Cell count and differential, peritoneal fluid

175

1.90

3.01

1.2

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.65

2.96

3.1

2.0

67.27

50.69

ug/l

0.45

(3021879) Hepatitis B virus core Ab [Presence] in Serum

138

1035

1.36

2.93

1.4

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

4.72

2.92

1.3

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

108

2.15

2.91

2.5

2.0

1.82

1.87

u/field

0.02

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

163

1.92

2.91

1.2

1.3

23.13

32.23

u/l

0.98

130

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

4.11

2.88

1.1

1.5

—

mmol/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

339

2865

1.23

2.86

1.3

26.40

29.57

iu/ml

0.30

928

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

159

1224

1.33

2.85

4.1

2.7

52.30

67.30

ml/min/173m2

4.15

520

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.66

2.79

1.9

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.46

2.79

1.8

2.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.46

2.79

1.6

2.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.48

2.79

1.9

2.3

401.80

1096.90

e6/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

8.35

2.75

1.0

1.2

—

(3025130) Human papilloma virus identified in Specimen

199

0.35

2.67

1.3

1.9

—

(3023383) Lactate [Moles/volume] in Pleural fluid

2.94

2.62

1.6

1.5

3.42

3.14

mmol/l

0.18

(3022689) Creatine [Moles/volume] in Urine

2.94

2.62

1.1

1.3

8.29

7.80

mmol/l

0.11

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

120

2.01

2.61

1.0

1.1

110.25

108.15

pmol/l

0.05

120

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

149

1.89

2.57

1.3

1.1

—

67.50

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

128

1.97

2.56

1.4

1.2

0.63

0.65

u/ml

0.01

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.14

2.55

2.0

2.4

414.00

586.54

e6/l

0.67

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.74

2.55

1.3

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.74

2.55

3.8

2.9

0.64

0.60

mmol/l

0.75

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

174

2170

0.78

2.53

1.4

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1413

13666

1.25

2.47

5.3

4.3

1.70

1.29

mmol/l

49.74

1252

12606

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

415

1.51

2.47

1.4

—

(40768800) Prostate Pathology biopsy report

332

0.48

2.36

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

207

1694

1.25

2.35

13.5

6.7

—

(3028433) Virus identified in Specimen by Culture

2.83

2.34

1.5

1.4

—

(40768441) Liver Pathology biopsy report

105

2.01

2.31

2.0

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.13

2.29

1.3

1.2

82.83

81.45

u/l

0.03

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

310

2658

1.21

2.25

1.3

11.04

11.90

u/ml

0.07

105

1039

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.90

2.25

9.9

5.8

5.00

5.32

mmol/l

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.90

2.25

1.0

1.1

111.00

93.50

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

225

1.66

2.22

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.51

2.18

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.31

2.15

1.7

3.4

1.29

1.31

0.02

(3010838) Calcium [Moles/time] in 24 hour Urine

278

1.56

2.04

2.0

1.8

4.78

5.17

mmol/24h

0.21

243

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

178

1457

1.25

2.04

2.9

2.4

31.06

40.15

u/l

1.40

143

1239

(3050129) First trimester maternal screen panel - Serum or Plasma

177

0.39

2.03

2.4

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

287

1.55

2.01

9.8

3.9

29.51

26.11

mg/l

0.24

196

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.06

2.01

1.3

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.97

2.00

2.4

2.1

—

(3022621) pH of Urine by Test strip

145

1161

1.27

2.00

4.4

2.5

6.13

6.06

0.44

107

778

(3002256) Pathology report gross observation

239

2025

1.21

1.97

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.99

1.95

1.1

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

473

1.41

1.92

1.6

1.5

0.04

0.09

iu/ml

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1433

13949

1.22

1.92

36.2

15.4

77.92

80.30

ml/min/173m2

3.07

1379

12969

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

101

777

1.32

1.89

2.2

3.6

33.51

82.88

u/ml

2.03

755

(3006922) Hepatitis E virus Ab [Presence] in Serum

100

1.91

1.85

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

229

1.58

1.85

1.1

1.2

4.79

4.48

u/ml

0.03

(4035726) Immunohistochemistry procedure

166

1365

1.24

1.84

1.5

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

101

1.89

1.81

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

101

1.89

1.81

1.8

1.5

90.37

79.64

umol/l

0.29

101

(3047189) Immunofixation for 24 hour Urine

2.01

1.80

1.4

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.01

1.80

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.05

1.80

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

301

2630

1.18

1.77

3.9

2.9

1.41

1.03

e6/l

1.13

170

1403

(3023323) Follitropin [Units/volume] in Serum or Plasma

636

1.34

1.77

1.3

20.71

31.85

iu/l

3.23

550

(3052851) Hemolysis interference index of Serum or Plasma

413

1.42

1.77

5.0

3.4

1.70

2.01

index

0.22

227

(3043238) Trisomy 21 risk [Likelihood] in Fetus

135

0.37

1.75

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

132

1.75

1.74

1.3

1.1

—

36.33

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.14

1.71

1.0

1.3

158.00

174.11

mmol/24h

0.31

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.51

1.66

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

692

6444

1.13

1.63

2.2

1.9

1.74

1.35

mmol/l

14.18

506

5445

(3034274) Bile acid [Moles/volume] in Serum --fasting

1.85

1.62

1.8

2.1

6.61

6.24

umol/l

0.06

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

556

0.68

1.61

2.4

1.8

—

(3014891) Appearance of Pleural fluid

3.01

1.58

2.3

1.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.01

1.58

1.2

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

402

3622

1.15

1.58

3.1

2.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.70

1.58

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

157

0.44

1.55

1.7

1.5

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.34

1.52

1.4

1.2

1.26

1.37

umol/l

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

1.52

0.0

1.0

—

43.52

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

129

0.39

1.48

1.4

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

147

1.64

1.48

3.5

4.1

50.47

79.38

u/ml

0.47

147

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

227

1.51

1.47

1.1

1.2

3.33

6.18

u/ml

1.06

102

(3036489) Thrombin time

577

1.31

1.46

1.6

2.0

20.98

21.00

0.01

518

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.13

1.44

1.6

2.9

0.80

0.69

u/field

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

398

1.37

1.40

1.3

1.1

—

(3025577) Chromium [Mass/volume] in Blood

1.86

1.40

1.8

2.2

1.97

1.80

ug/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.42

1.39

1.0

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1068

0.78

1.39

2.3

2.5

14.56

19.66

au/ml

—

105

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

120

0.41

1.37

1.0

28.18

43.63

ng/l

—

(3032057) Clostridioides difficile [Presence] in Stool

2.61

1.37

1.7

1.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

400

1.36

1.3

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.95

1.36

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

403

1.35

1.31

1.3

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.10

1.30

1.9

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.79

1.27

1.4

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.79

1.27

1.3

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

118

0.42

1.24

1.0

701.80

694.68

ng/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

119

0.42

1.24

1.0

176.80

307.89

ng/l

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.78

1.17

1.6

2.8

737.43

1216.37

u/ml

0.72

(1617658) Protocol used for examination of sentinel lymph nodes

130

0.46

1.16

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

698

1.24

1.15

4.2

3.5

1.02

ratio

1.30

637

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.38

1.09

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.38

1.09

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.38

1.09

1.2

1.0

—

(3002619) Bacteria identified in Specimen by Culture

2.19

1.08

1.0

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

490

1.28

1.05

1.5

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

121

0.49

1.05

1.3

1.4

—

(3006462) Nitrate [Presence] in Urine

1.96

1.03

2.2

3.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

1.77

1.00

1.0

9.6

73.57

61.19

mg/l

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

148

1.49

0.98

1.3

86474.81

126444.28

e6/l

0.16

(1761868) Lipid panel - Serum or Plasma

611

5777

1.09

0.97

4.4

3.2

—

(3023410) Appearance of Cerebral spinal fluid

174

0.57

0.96

1.4

1.6

—

(4211845) Urine protein measurement

1.86

0.96

2.2

3.1

—

(3034426) Prothrombin time (PT)

1.80

0.96

1.0

1.3

28.22

28.50

—

(40768446) Kidney Pathology biopsy report

1.80

0.96

1.3

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

108

1265

0.84

0.95

3.2

2.4

9.73

13.66

nmol/l

5.36

1145

(4268621) Lupus anticoagulant assay

166

1.45

0.94

2.1

2.3

—

(3028717) Thiamine [Mass/volume] in Blood

2.23

0.93

1.2

65.50

68.93

ug/l

—

(3018133) Calcium [Moles/volume] in Urine

2.23

0.93

2.7

2.1

2.48

3.41

mmol/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.15

0.91

1.2

1.4

0.81

1.23

mmol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.15

0.91

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1540

15230

1.19

0.90

49.6

20.7

87.71

77.07

umol/l

11.39

1525

15085

(3023511) Choriogonadotropin [Units/volume] in Urine

143

1.47

0.90

1.6

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.91

0.88

1.5

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.91

0.88

1.8

1.5

—

(3051651) Icteric interference index of Serum or Plasma

1.58

0.87

3.4

4.1

0.53

0.89

index

1.24

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

212

1.37

0.86

1.3

1.1

—

18.00

—

(1761482) Bacteria [#/volume] in Urine by Culture

308

1.31

0.86

4.9

4.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.78

0.84

1.3

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.78

0.84

1.4

1.2

115.50

106.30

—

(3032773) Endomysium IgG Ab [Titer] in Serum

137

0.58

0.83

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

455

0.76

0.83

2.2

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

380

3543

1.09

0.82

5.1

3.6

0.20

0.18

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

185

1660

1.13

0.82

3.1

4.4

33.10

19.92

ug/l

0.28

151

1352

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.67

0.78

1.6

2.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.51

0.78

1.4

64.66

240.17

pmol/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.77

0.0

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

115

1005

1.16

0.76

1.2

170.25

144.04

u/ml

0.15

385

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.76

0.0

1.1

—

48.49

—

(3016228) CD19 cells/cells in Blood

1.64

0.73

3.0

1.7

9.44

7.07

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.58

0.71

2.9

1.7

28.56

31.04

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.93

0.70

1.0

1.2

—

216.40

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.93

0.70

1.2

1.3

1.88

1.78

mmol/l

—

(44813793) Dust mix specific IgE antibody measurement

1.51

0.69

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.64

0.68

1.5

1.9

38.52

41.29

g/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

168

0.65

0.67

1.3

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.54

0.67

2.2

1.8

—

(36660697) Celiac disease serology panel - Serum

129

1151

1.13

0.66

1.2

—

(3010813) Leukocytes [#/volume] in Blood

1538

15501

0.87

0.64

56.8

24.2

7.99

6.62

e9/l

93.37

1510

15156

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

177

0.68

0.63

3.6

2.1

13.69

13.23

0.96

177

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.52

0.62

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

244

2265

1.09

0.60

1.5

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.60

0.0

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

2.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

1539

15504

0.88

0.59

57.4

24.3

132.37

135.58

g/l

11.12

1528

15351

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.59

0.0

3.3

—

48.00

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.59

0.0

6.5

—

7.95

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.53

0.59

1.7

1.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.72

0.57

1.5

1.2

—

0.50

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1539

15501

0.88

0.57

57.9

24.7

40.86

40.43

2.34

1527

15341

(3026361) Erythrocytes [#/volume] in Blood

1539

15501

0.88

0.57

56.6

24.2

4.55

4.49

e12/l

3.86

1515

15158

(3035941) MCH [Entitic mass]

1539

15501

0.88

0.57

56.4

24.1

29.44

30.42

55.88

1528

15347

(3029075) Extractable nuclear Ab panel - Serum

1.49

0.57

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.67

0.56

1.2

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.51

0.56

1.0

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1539

15499

0.88

0.55

56.4

24.1

91.18

91.32

0.46

1528

15347

(3019832) Treponema pallidum Ab [Presence] in Serum

920

0.87

0.55

1.7

1.6

—

(3008898) HLA-B27 [Presence]

503

0.83

0.54

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

473

4942

0.94

0.54

4.5

5.4

1.93

2.58

ug/l

0.94

407

4497

(3007461) Platelets [#/volume] in Blood

1539

15497

0.88

0.54

56.7

24.2

254.79

249.94

e9/l

2.06

1520

15204

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.48

0.53

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

1.49

0.53

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

362

3434

1.07

0.53

6.1

3.9

1.02

1.46

kg/l

0.50

264

2300

(4094501) Cardiovascular stress test using bicycle ergometer

446

0.83

0.52

1.1

—

(40768795) Lymph node Pathology biopsy report

161

1.31

0.52

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

499

0.84

0.51

1.3

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.52

0.48

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.49

0.47

1.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

137

1.32

0.47

1.3

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

612

0.86

0.47

2.0

3.5

1417.13

2500.18

u/ml

0.23

531

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

117

0.68

0.46

1.6

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.56

0.42

6.2

7.7

5.96

5.19

kpa

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

158

1.27

0.41

1.1

—

(3017704) Immunofixation for Urine

1.36

0.41

1.3

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.52

0.41

1.6

1.18

1.19

mmol/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

777

1.11

0.41

2.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.47

0.40

1.0

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

64.00

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

421

0.85

0.39

1.3

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

367

0.84

0.39

1.4

158.23

234.42

e6/l

0.23

289

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

106

1.32

0.39

1.1

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

8.41

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

438

1.15

0.38

1.4

1.2

2.33

2.59

u/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.33

0.37

1.0

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

290

1.18

0.37

1.2

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.29

0.36

1.3

30.11

28.61

umol/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

146

0.75

0.36

2.7

5.6

—

43.63

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

263

1.18

0.36

1.5

1.7

—

(3018333) Ribosomal P Ab [Presence] in Serum

108

1.30

0.35

1.4

1.1

—

(3042733) HLA Ab [Presence] in Serum

1.40

0.35

2.3

4.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

362

0.85

0.34

1.3

1.4

9.90

43.90

e6/l

0.87

270

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

189

0.79

0.34

1.1

11.18

2.63

eliau/ml

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.36

0.34

3.8

1.5

2.08

1.78

ratio

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

209

1.20

0.34

1.8

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1469

14589

1.07

0.33

7.0

5.9

2.34

2.73

mmol/l

59.35

1324

13601

(37208534) Antinuclear antibody arbitrary concentration in serum

1.28

0.32

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

111

1.26

0.30

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

111

1.26

0.30

1.4

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

297

1.15

0.29

1.2

1.4

—

10.45

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1521

15131

1.07

0.29

19.1

12.3

27.76

26.19

u/l

2.11

1485

14737

(3013139) Helicobacter pylori Ag [Presence] in Stool

1012

0.92

0.29

1.2

1.3

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.27

0.27

1.4

1.3

18.13

9.48

mm/h

—

(3014051) Protein [Presence] in Urine by Test strip

431

4189

1.04

0.27

3.8

3.0

0.11

0.02

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

442

1.11

0.27

1.4

1.2

4.00

9.51

u/ml

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.27

0.26

2.8

1.7

122.10

99.38

ng/l

0.46

(3047007) Chlamydophila sp Ab [Presence] in Serum

214

0.84

0.26

1.4

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

415

1.11

0.26

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.67

0.26

1.0

1.1

1687.60

1655.81

miu/ml

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.22

0.25

1.1

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.22

0.25

1.1

1.6

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1207

11962

1.03

0.23

43.8

19.7

15.02

13.62

119.90

1194

11794

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

115

1.22

0.23

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

115

1.22

0.23

1.4

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.32

0.23

1.0

1.1

—

945.45

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

200

0.85

0.22

2.6

2.2

—

9.00

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.76

0.22

1.6

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

116

1.21

0.22

1.4

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

273

0.88

0.21

1.1

1.2

334.33

269.62

u/ml

0.34

161

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.05

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

3.12

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.00

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.21

0.0

1.2

—

15.62

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.23

0.20

1.0

1.3

7.66

9.11

ug/l

—

(3003694) ABO and Rh group [Type] in Blood

399

4081

0.97

0.19

1.5

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

146

1.17

0.19

1.2

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

415

1.09

0.18

2.1

2.2

376.03

4.30

iu/l

0.47

169

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.21

0.17

1.4

1.3

17.69

6.57

u/l

0.43

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.72

0.17

1.4

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

408

1.08

0.16

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.14

0.16

1.5

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

177

1.13

0.16

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.13

0.16

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

224

0.89

0.15

1.1

1.0

4.25

4.28

u/ml

0.00

112

(3038177) Helicobacter pylori Ab [Presence] in Serum

233

0.90

0.14

1.4

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

160

1.13

0.14

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

122

1.15

0.13

1.4

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

459

0.94

0.13

2.1

1.9

32.70

40.74

nmol/l

2.34

444

(3003740) Influenza virus B Ag [Presence] in Specimen

257

1.09

0.13

1.2

1.1

—

(40768793) Breast Pathology biopsy report

374

1.07

0.13

1.4

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.16

0.11

1.3

1.5

55.54

55.96

ug/l

0.01

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1443

14388

1.02

0.10

6.3

5.2

4.16

4.68

mmol/l

72.91

1304

13470

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.4

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.11

0.09

1.6

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.11

0.09

1.4

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.09

0.09

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.09

0.09

4.2

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

207

0.92

0.09

1.1

—

3.71

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.06

0.09

1.6

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

107

1101

0.97

0.09

2.0

1.8

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.11

0.09

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.11

0.09

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.11

0.09

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.11

0.09

1.3

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

216

0.93

0.08

1.1

0.35

1.78

u/ml

—

(4034850) Laboratory test

440

1.05

0.08

25.6

10.1

—

(3005570) Glucose [Moles/volume] in Urine

156

1.09

0.08

4.4

2.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

717

1.03

0.08

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

265

0.94

0.07

1.0

1.1

0.54

1.71

u/ml

1.19

142

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

132

0.91

0.06

1.5

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

168

1.07

0.06

1.6

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

178

1.07

0.05

1.0

1.1

1.76

3.03

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

258

1.05

0.04

1.2

1.1

—

(4024509) Urine culture

706

1.02

0.04

2.2

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

191

1.05

0.03

1.0

1.1

5.04

2.07

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

209

0.96

0.03

1.4

0.20

0.31

nmol/l

1.59

154

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

118

0.93

0.02

1.0

1.2

24.40

37.99

mg/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

100

991

1.01

0.01

2.0

1.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1432

14311

1.01

0.01

6.3

5.1

1.23

1.48

mmol/l

100.48

1287

13308

(40768804) Tissue Pathology biopsy report

599

5998

1.00

0.00

2.1

2.2

—

(3045142) Bone marrow Pathology biopsy report

194

1.03

0.00

1.1

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

114

0.96

0.00

1.0

1.1

—

(21494434) Karyotype in Bone marrow

148

1.01

0.00

1.1

1.3

—

(1002224) Polysomnography panel

716

1.01

0.00

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

668

1.00

0.00

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

113

0.97

0.00

1.0

1.1

240.33

274.67

mg/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

163

0.98

0.00

1.0

0.14

0.19

u/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

413

0.99

0.00

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

335

0.98

0.00

1.4

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

37.84

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

23.01

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

4.1

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

8.59

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1745.20

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

93.00

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(4038314) Semen analysis, post vasectomy

0.00

-0.00

0.0

1.2

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.91

-0.00

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.62

—

(3022475) Manganese [Moles/volume] in Blood

0.00

-0.00

0.0

1.4

—

0.16

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.7

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.18

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.2

—

403.40

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

3.9

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

390

1.00

-0.00

1.3

1.2

80.90

211.73

miu/ml

—

175

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.6

—

6.86

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

3.74

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

210

1.00

-0.00

1.0

1.1

1.26

1.57

u/ml

—

103

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.02

-0.00

1.6

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

0.06

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITYXTRMALV and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITYXTRMALV	4.928 [4.15, 5.85]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.785

During the follow-up period (1.1.1998 — 31.12.2019), 1150 out of 3720 females with E4_OBESITYXTRMALV died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITYXTRMALV	4.648 [3.91, 5.52]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1186 out of 3284 males with E4_OBESITYXTRMALV died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITYXTRMALV.

N-year risk	Females	Males
1	0.708%	0.697%
5	3.189%	4.419%
10	7.568%	11.367%
15	13.934%	20.929%
20	25.508%	33.412%

Relationships between endpoints

↥

Index endpoint: E4_OBESITYXTRMALV – Extreme obesity with alveolar hypoventilation

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Extreme obesity with alveolar hypoventilation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints